ArticlePDF AvailableLiterature Review

Abstract and Figures

Ethnopharmacological relevance Withania somnifera (Family: Solanaceae), commonly known as Ashwagandha or Indian ginseng is distributed widely in India, Nepal, China and Yemen. The roots of plant consist of active phytoconstituents mainly withanolides, alkaloids and sitoindosides and are conventionally used for the treatment of multiple brain disorders. Aim of the review: This review aims to critically assess and summarize the current state and implication of Ashwagandha in brain disorders. We have mainly focussed on the reported neuroactive phytoconstituents, available marketed products, pharmacological studies, mechanism of action and recent patents published related to neuroprotective effects of Ashwagandha in brain disorders. Materials and methods All the information and data was collected on Ashwagandha using keywords “Ashwagandha” along with “Phytoconstituents”, “Ayurvedic, Unani and Homeopathy marketed formulation”, “Brain disorders”, “Mechanism” and “Patents”. Following sources were searched for data collection: electronic scientific databases such as Science Direct, Google Scholar, Elsevier, PubMed, Wiley On-line Library, Taylor and Francis, Springer; books such as AYUSH Pharmacopoeia; authentic textbooks and formularies. Results Identified neuroprotective phytoconstituents of Ashwagandha are sitoindosides VII–X, withaferin A, withanosides IV, withanols, withanolide A, withanolide B, anaferine, beta-sitosterol, withanolide D with key pharmacological effects in brain disorders mainly anxiety, Alzheimer's, Parkinson's, Schizophrenia, Huntington's disease, dyslexia, depression, autism, addiction, amyotrophic lateral sclerosis, attention deficit hyperactivity disorder and bipolar disorders. The literature survey does not highlight any toxic effects of Ashwagandha. Further, multiple available marketed products and patents recognized its beneficial role in various brain disorders; however, very few data is available on mechanistic pathway and clinical studies of Ashwagandha for various brain disorders is scarce and not promising. Conclusion The review concludes the results of recent studies on Ashwagandha suggesting its extensive potential as neuroprotective in various brain disorders as supported by preclinical studies, clinical trials and published patents. However vague understanding of the mechanistic pathways involved in imparting the neuroprotective effect of Ashwagandha warrants further study to promote it as a promising drug candidate.
Content may be subject to copyright.
UNCORRECTED PROOF
#CIFB5@C:H<BCD<5FA57C@C;M LLL LLLL LLLLLL
CBH9BHG@=GHG5J5=@56@95H,7=9B79=F97H
#CIFB5@C:H<BCD<5FA57C@C;M
>CIFB5@<CA9D5;9<HHD99G9@G9J=9F7CA
G<K5;5B8<5 =B 6F5=B 8=GCF89FG F9J=9K C: F979BH 89J9@CDA9BHG
,I@H5B 35<=FI88=B )5F5?< 5G=GH 6=85 )5FJ99B +5695 )5FJ99B 05G<=A $<5B 5IF5J ,5M998 <A58
Bioactive Natural Product Laboratory, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India
+-"% "'(
Keywords
G<K5;5B8<5
)<MHC7CBGH=HI9BHG
2.,! DFC8I7HG
F5=B 8=GCF89FG
&97<5B=GA 5B8 D5H9BHG
,-+-
Ethnopharmacological relevance: Withania somnifera 5A=@M ,C@5B57959 7CAACB@M ?BCKB 5G G<K5;5B8<5 CF
"B8=5B ;=BG9B; =G 8=GHF=6IH98 K=89@M =B "B8=5 '9D5@ <=B5 5B8 29A9B -<9 FCCHG C: D@5BH 7CBG=GH C: 57H=J9 D<M
HC7CBGH=HI9BHG A5=B@M K=H<5BC@=89G 5@?5@C=8G 5B8 G=HC=B8CG=89G 5B8 5F9 7CBJ9BH=CB5@@M IG98 :CF H<9 HF95HA9BH C:
AI@H=D@9 6F5=B 8=GCF89FG=A C: H<9 F9J=9K -<=G F9J=9K 5=AG HC 7F=H=75@@M 5GG9GG 5B8 GIAA5F=N9 H<9 7IFF9BH GH5H9
5B8 =AD@=75H=CB C: G<K5;5B8<5 =B 6F5=B 8=GCF89FG 09 <5J9 A5=B@M :C7IGG98 CB H<9 F9DCFH98 B9IFC57H=J9 D<M
HC7CBGH=HI9BHG 5J5=@56@9 A5F?9H98 DFC8I7HG D<5FA57C@C;=75@ GHI8=9G A97<5B=GA C: 57H=CB 5B8 F979BH D5H9BHG
DI6@=G<98 F9@5H98 HC B9IFCDFCH97H=J9 9::97HG C: G<K5;5B8<5 =B 6F5=B 8=GCF89FG
Materials and methods: @@ H<9 =B:CFA5H=CB 5B8 85H5 K5G 7C@@97H98 CB G<K5;5B8<5 IG=B; ?9MKCF8G G<K5
;5B8<55@CB; K=H< )<MHC7CBGH=HI9BHGMIFJ98=7 .B5B= 5B8 !CA9CD5H<M A5F?9H98 :CFAI@5H=CBF5=B 8=G
CF89FG&97<5B=GA5B8 )5H9BHG C@@CK=B; GCIF79G K9F9 G95F7<98 :CF 85H5 7C@@97H=CB 9@97HFCB=7 G7=9BH=Q7
85H565G9G GI7< 5G ,7=9B79 =F97H CC;@9 ,7<C@5F @G9J=9F )I6&98 0=@9M (B@=B9 %=6F5FM -5M@CF 5B8 F5B7=G
,DF=B;9F 6CC?G GI7< 5G 2.,! )<5FA57CDC9=5 5IH<9BH=7 H9LH6CC?G 5B8 :CFAI@5F=9G
Results: "89BH=Q98 B9IFCDFCH97H=J9 D<MHC7CBGH=HI9BHG C: G<K5;5B8<5 5F9 G=HC=B8CG=89G /""1 K=H<5:9F=B  K=H<
5BCG=89G "/ K=H<5BC@G K=H<5BC@=89  K=H<5BC@=89  5B5:9F=B9 69H5G=HCGH9FC@ K=H<5BC@=89 K=H< ?9M D<5FA5
7C@C;=75@ 9::97HG =B 6F5=B 8=GCF89FG A5=B@M 5BL=9HM @N<9=A9FG )5F?=BGCBG ,7<=NCD<F9B=5 !IBH=B;HCBG 8=G95G9
8MG@9L=5 89DF9GG=CB 5IH=GA 588=7H=CB 5AMCHFCD<=7 @5H9F5@ G7@9FCG=G 5HH9BH=CB 89Q7=H <MD9F57H=J=HM 8=GCF89F 5B8
6=DC@5F 8=GCF89FG -<9 @=H9F5HIF9 GIFJ9M 8C9G BCH <=;<@=;<H 5BM HCL=7 9::97HG C: G<K5;5B8<5 IFH<9F AI@H=D@9
5J5=@56@9 A5F?9H98 DFC8I7HG 5B8 D5H9BHG F97C;B=N98 =HG 69B9Q7=5@ FC@9 =B J5F=CIG 6F5=B 8=GCF89FG <CK9J9F J9FM
:9K 85H5 =G 5J5=@56@9 CB A97<5B=GH=7 D5H<K5M 5B8 7@=B=75@ GHI8=9G C: G<K5;5B8<5 :CF J5F=CIG 6F5=B 8=GCF89FG =G
G75F79 5B8 BCH DFCA=G=B;
Conclusion: -<9 F9J=9K 7CB7@I89G H<9 F9GI@HG C: F979BH GHI8=9G CB G<K5;5B8<5 GI;;9GH=B; =HG 9LH9BG=J9 DCH9B
H=5@ 5G B9IFCDFCH97H=J9 =B J5F=CIG 6F5=B 8=GCF89FG 5G GIDDCFH98 6M DF97@=B=75@ GHI8=9G 7@=B=75@ HF=5@G 5B8 DI6@=G<98
D5H9BHG !CK9J9F J5;I9 IB89FGH5B8=B; C: H<9 A97<5B=GH=7 D5H<K5MG =BJC@J98 =B =AD5FH=B; H<9 B9IFCDFCH97H=J9
9::97H C: G<K5;5B8<5 K5FF5BHG :IFH<9F GHI8M HC DFCACH9 =H 5G 5 DFCA=G=B; 8FI; 75B8=85H9
1. Introduction
&9BH5@ <95@H< DFC6@9A 5B8 B9IFC@C;=75@ 8=GCF89FG 5F9 5 G9F=CIG DI6
@=7 <95@H< 7CB79FB ;@C65@@M K=H< ACF9 H<5B CB9 6=@@=CB GI::9F9FG KCF@8
K=89 CF B9IFC@C;=75@ 8=GCF89FG AC89FB A98=7=B9 C::9FG GMADHCA5H=7
HF95HA9BH H<5H =G 9LD9BG=J9 5B8 5GGC7=5H98 K=H< G9J9F5@ G=89 9::97HG '5H
IF5@ DFC8I7HG <5J9 699B 6FC58@M 9LD@C=H98 5G 5B =ADCFH5BH GCIF79 :CF
A98=7=B9 @5F;9 BIA69F C: A98=7=B9G 5F9 89F=J98 :FCA D@5BH65G98
9LHF57H=CBG 5B8 :F57H=CB5H=CB 5B8 <5J9 ;F95H =ADCFH5B79 :CF <IA5BG
'CK585MG A98=75@ DF57H=H=CB9FG 5F9 ACF9 =B7@=B98 HCK5F8G B5HIF5@
A98=7=B9G :CF 5 HFIGHKCFH<M HF95HA9BH K=H< 7CGH 9::97H=J9B9GG 5B8 @CK9F
=B7=89B79 C: G=89 9::97H
MIFJ985 5 DCDI@5F "B8=5B GMGH9A C: A98=7=B9 <5G 5 K9@@89J9@CD98
7CIFG9 C: 57H=CB :CF H<9 A5B5;9A9BH 5B8 HF95HA9BH C: 6F5=B 5GGC7=5H98
8=GCF89FG @=GH C: 56CIH  MIFJ98=7 A98=7=B5@ D@5BHG  DCDI@5F
D@5BH CF CB9 C: H<9=F =B;F98=9BHG C: MIFJ98=7 DF9G7F=DH=CBG 5F9 5J5=@
56@9 :CF B9IFC@C;=75@ 8=GCF89FG 5@?F=G<B5 5B8 &=GF5  (B9
C: H<9 HF58=H=CB5@ K9@@?BCKB "B8=5B A98=7=B5@ D@5BH =G G<K5;5B8<5
Withania somnifera K<=7< =G 5 7CAACB =B;F98=9BH C: G9J9F5@ MIFJ98=7
:CFAI@5H=CBG A5F?9H98 :CF H<9 HF95HA9BH C: B9IFC@C;=75@ 8=GCF89FG -<9
<9F65@ A5F?9H98 :CFAI@5H=CBG 5F9 GIAA5F=N98 =B -56@9
G<K5;5B8<5 69@CB;G HC H<9 :5A=@M ,C@5B57959 (H<9F 7CAACB
B5A9G C: G<K5;5B8<5 5F9 "B8=5B ;=BG9B; DC=GCB ;CCG969FFM 5B8 K=B
H9F 7<9FFM G<K5;5B8<5 =G 7I@H=J5H98 =B 'CFH< K9GH9FB 5B8 79B
CFF9GDCB8=B; 5IH<CF
E-mail address: G5<A584><M5<CC7C=B , <A58
EI5@ 7CBHF=6IH=CB
<HHDG8C=CF;>>9D
+979=J98  ,9DH9A69F +979=J98=BF9J=G98:CFA  #5BI5FM 779DH98  DF=@ 
J5=@56@9CB@=B9 LLL
P 
UNCORRECTED PROOF
S. Zahiruddin et al. Journal of Ethnopharmacology xxx (xxxx) xxx-xxx
Table 1
&5F?9H98 <9F65@ :CFAI@5H=CB C: G<K5;5B8<5 =B 6F5=B 8=GCF89FG
,'
'5A9C:H<9
:CFAI@5H=CB .G9G &5BI:57HIF9
,HF9GGK=B +9@=9J9GHF9GG
BH=89DF9GG5BH&9ACFM
9B<5B79A9BH
5=8M5B5H<
MIFJ98<5K5B
,HF9GG7CA +9@=9J9GHF9GG
BH=89DF9GG5BH
56IF"B8=5%H8
G<K5;5B8<5F=GH5 &9ACFM9B<5B79A9BH
,@99D=B8I7H=CB
5=8M5B5H<
MIFJ98<5K5B
!=A5@5M5
G<K5;5B8<5
BH=GHF9GG -<9!=A5@5M5FI;
CAD5BM
AFI?<5?5GHIF= '9IFC5GH<9B=5
CBJ5@9G79B79
)5B?5>5?5GH<IF=
!9F65@"B8=5)JH
%H8
'5HIF9
G<K5;5B8<5
BH=GHF9GG '5HIF9MIFJ985
5FIGCG
G<K5;5B8<5
BH=GHF9GGBH=5BL=9HM 5FIGCG'5HIF5@
!95@H<
,AFIH=<=@@G &9ACFM9B<5B79A9BH
BH=GHF9GG
!9F65@!=@@G
F9BHC '9FJ=B9HCB=7 35B8I
)<5FA579IH=75@
0CF?G%H8
 ,HF9GG,<=9@8 BH=GHF9GGBH=5BL=9HM IF9J985
 C@89B&=@? &9ACFM9B<5B79A9BH 5=5!9F6
HF5@ D5FH C: "B8=5 "B "B8=5 &58<M5 )F589G< I>5F5H !5FM5B5 &5<5
F5G<HF5 )IB>56 +5>5GH<5B 5B8 .HH5F )F589G< 5F9 H<9 A5=B DFC8I7=B;
GH5H9 C: G<K5;5B8<5 "H =G 5@GC :CIB8 =B '9D5@ <=B5 5B8 29A9B -<9
7@=A5H=7 7CB8=H=CBG F9EI=F98 :CF H<9 7I@H=J5H=CB C: G<K5;5B8<5 =B7@I89
5B 5@H=HI89 C:  A 56CJ9 H<9 G95 @9J9@ -<9 G9A= HFCD=75@ F9;=CBG
K<=7< F979=J9 56CIH  AA 5BBI5@ F5=B:5@@ 5F9 H<9 69GH GI=H98 :CF
=HG 7I@H=J5H=CB -<9 7FCDG F9EI=F9 8FM 7CB8=H=CB 8IF=B; ;FCK=B; D9F=C8G
5B8 CDH=AIA H9AD9F5HIF9 F9EI=F98 :CF =HG 7I@H=J5H=CB =G  O -<9
G5B8M @C5A CF @=;<H F98 GC=@ 5B8 D5FH=5@ G<589 GIB 5F9 CH<9F GI=H56@9 :57
HCFG :CF =HG ;FCKH< $I@?5FB= 5B8 <=F &=F>5@=@= 9H 5@ 
5F 9H 5@ 
-<9 9LHF57H C: FCCHG 7CBH5=BG GH9FC=85@ @57HCB9G K=H< 9F;CGH5B9 K<=7<
7CBH5=B K=H<5BCB9 K=H<5:9F=B K=H<5BC@=89G G=HC=B8CG=89G 5B8 56CIH
 5@?5@C=8G /5F=CIG GHI8=9G <5J9 699B 7CB8I7H98 CB 57H=J9 D<MHC
7CBGH=HI9BHG K<=7< <9@DG =B DFCJ=8=B; 5 F5H=CB5@9 657?;FCIB8 :CF 8FI;
89G=;B K=H< ID;F5898 5B8 69HH9F D<5FA57C@C;=75@ DFCD9FH=9G -<9 <9F6
=G F9DCFH98 HC DCGG9GG 69B9Q7=5@ 9::97HG =B 5 K=89 F5B;9 C: B9IFC@C;=75@
8=GCF89FG =B7@I8=B; GHF9GG )5F?=BGCBG 8=G95G9 !IBH=B;HCBG 8=G95G9 5B8
@N<9=A9FG 8=G95G9 9H7 G<K5;5B8<5 AC8I@5H9G H<9 6F5=B CL=85H=J9
GHF9GG A5?9FG GI7< 5G GID9FCL=89 8=GAIH5G9 ,( 75H5@5G9 @=D=8 D9FCL
=85H=CB %)( 5B8 BCB9BNMA5H=7 5BH=CL=85BHG @=?9 ;@IH5H<=CB9  ,!
-<9 FCCHG 5B8 =HG 9LHF57H =B8I79 5LCB 5B8 89B8F=H9 CIH;FCKH< DFCDCG=B;
=HG DCGG=6@9 9::97H CB B9IFCB5@ F9;9B9F5H=CB IF; 9H 5@ 
G<K5;5B8<5 CB H<9 65G=G C: D<MHCD<5FA57C@C;=75@ GHI8=9G DFCJ98
DCH9BH=5@ 5G 5BH==BR5AA5HCFM 5BH=CL=85BH 5BH=75B79F 5BH=A=7FC6=5@
5BH=A5@5F=5@ 8=IF9H=7 G985H=J9 =AAIACBC8I@5HCFM 5B8 75F8=CDFCH97
H=J9 DFCD9FH=9G #C<B -<=G GHI8M 5=AG HC 9LD@CF9 5B8 9J5@I5H9
H<9 @=H9F5HIF9 D9FH5=B=B; HC H<9 FC@9 C: G<K5;5B8<5 =B B9IFC@C;=75@ 8=G
CF89FG IFH<9F H<9 DF9G9BH D=979 C: KCF? 7CAD=@9G B9IFC@C;=75@ =B:CF
A5H=CB C: G<K5;5B8<5 9LHF57HG 5B8 =HG =GC@5H98 7CADCIB8G IG98 =B
H<9 B9IFC@C;=75@ F9G95F7< GHI8=9G 5B8 @5H9GH DI6@=G<98 D5H9BHG "',+-
-56@9
2. Phytoconstituents of Ashwagandha
G<K5;5B8<5 7CBH5=BG J5F=CIG BCBBIHF=H=CB5@ 7<9A=75@G F9GDCB
G=6@9 :CF A98=7=B5@ DFCD9FH=9G &CF9 H<5B  D<MHC7<9A=75@G 5F9 =GC
@5H98 5B8 =89BH=Q98 =B G<K5;5B8<5 &5=B 7<9A=75@ 7CBGH=HI9BHG 5F9
5@?5@C=8G 5B8 GH9FC=85@ @57HCB9 ,CAB=:9F=B9 GCAB=B9 GCAB=:9F=B=B9
K=H<5B5B=B9 DG9I8CK=H<5B=B9 HFCD=B9 DG9I8CHFCD=B9 5;@CM
@CLMHFCD5B9 7IG7C<M;F=B9 5B8 5B5:9F=B9 5F9 H<9 5@?5@C=8G DF9G9BH =B
G<K5;5B8<5 K=H< K=H<5B=B9 69=B; H<9 A5>CF CB9 -<9 A5=B GH9FC=85@
@57HCB9G 5F9 K=H<5:9F=B  K=H<5BC@=89G 2 K=H<5GCAB=:9F=B K=H<
5GCA=8=9BCB9 K=H<5GCAB=:9FC@G  K=H<5BCB9 IDH5 5B8 +5B5
 -<9 A5>CF D<MHC7CBGH=HI9BHG C: G<K5;5B8<5 5F9 89D=7H98 =B
=; 5B8 H<9=F F9@5H=J9 DFCD9FH=9G =B 6F5=B 8=GCF89FG 5F9 GIAA5F=N98 =B
-56@9
3. Historical background of Ashwagandha
-F58=H=CB5@ A98=7=B5@ GMGH9A =G H<9 DCH9BH=5@ H<9F5D9IH=7 CDH=CB HC
HF95H K=89 F5B;9 C: 8=GCF89FG K=H< @=A=H98 G=89 9::97HG =ADFCJ98 9:Q
757M 5B8 H<IG CK=B; DFCD9FHM HC A5B5;9 H<9 8=G95G9 5H 8=::9F9BH @9J9@G
=B7@I8=B; DF9J9BH=CB 5B8 7IF9 G<K5;5B8<5 =G 5B =ADCFH5BH <9F6 =B
J5F=CIG HF58=H=CB5@ GMGH9A C: A98=7=B9 DFC@=:=75@@M MIFJ985 .B5B= ,=8
8<5 !CA9CD5H<M <=B9G9 -=69H5B :F=75B 9H7 "B Withania somnifera
GCAB=:9F5=G 5 %5H=B KCF8 K<=7< A95BG G@99D=B8I79F H<IG >IGH=:M
=B; =HG IG9 9LH9BG=J9@M 5G B9IFCDFCH97H=J9 "H =G ?BCKB 6M 8=::9F9BH @C75@
B5A9G =B 8=::9F9BH D5FHG C: "B8=5
-<9 HF58=H=CB5@ "B8=5B A98=7=B5@ GMGH9A MIFJ985 5B8 <=B9G9
A98=7=B5@ GMGH9A 5F9 H<9 ACGH 5B7=9BH GMGH9AG MIFJ985 F9EI=F98 ACF9
9J=89B79G 5B8 G7=9BH=Q765G98 F9G95F7< )5HK5F8<5B 9H 5@  "B
MIFJ985 =H =G ?BCKB 5G G<K5;5B8<5 K<=7< A95BG C8CIF C: H<9
<CFG95G =H FCCHG F9G9A6@9 GK95HM <CFG9 "H <5G 699B 9LH9BG=J9@M IG98
:FCA D5GH H<CIG5B8 M95FG 657? HC HF95H K=89 F5B;9 C: 8=G95G9G MIFJ98=7
DF57H=H=CB9FG HF58=H=CB5@@M IG9 =H 6M 6C=@=B; H<9 :F9G< FCCHG =B A=@? "H 5@GC
58A=B=GH9F98 6M 7FIG<=B; H<9 FCCHG =BHC QB9 DCK89F 75@@98 5G 7<IFB5
5B8 6@9B8=B; =H K=H< RI=8G A5=B@M K5H9F A=@? <CB9M (H<9F D5FHG =B
7@I8=B; @95J9G G<CCHG G998G 5B8 69FF=9G <5J9 5@GC 699B IG98 HC =A
DFCJ9 <95@H< 5B8 =B7F95G9 @CB;9J=HM "B MIFJ98=7 GMGH9A =H =G 7@5GG=
Q98 5G +5G5M5B5A95BG HCB=75B8 A5=B@M 57H 5G 6C8M F9>IJ9B5HCF
89:9BG9 5;5=BGH 8=G95G9 G@CKG 5;=B; 5B8 9B<5B79G A9ACFM ,5A58=
CFA5B 5B8 $9FB5 
.B5B= =G 5 HF58=H=CB5@ :CFA C: A98=7=B9 GMGH9A A5=B@M =B &=88@9
5GH 5B8 ,CIH< G=5B 7CIBHF=9G "H =G 65G98 CB H<9 DF=B7=D@9 C: 9EI=@=6
F=IA 5B8 H<9F5D=9G 9AD@CM D<MG=75@ A95BG :CF 8=G95G9 7IF=B; "H 9A
D@CMG 58A=B=GHF5H=CB C: 9=H<9F GD97=Q7 8=9H CF AC8I@5H=CB =B EI5@=HM 5B8
EI5BH=HM C: :CC8 '5HIF5@ GI6GH5B79G 9=H<9F G=B;@9 8FI;G CF 7CA6=B5H=CB
C: HKC CF ACF9 8FI;G 5F9 IG98 :CF HF95H=B; 5=@A9BHG ,<=885A5@@5MM5
9H 5@  0=H<5B=5 GCAB=:9F5 =G ?BCKB 5G G;5B8 =B .B5B= GMG
H9A 5B8 =G 89G7F=698 =B 6CC? Kitab-ul-Hashaish 77CF8=B; HC @=H9F5
HIF9 Asgand Nagori 5B8 Asgand Dakani 5F9 H<9 HKC J5F=9H=9G ?BCKB =B
.B5B= GMGH9A <CK9J9F Asgand Nagori =G A98=75@@M ACF9 DF9:9FF98 .8
8=B 9H 5@  "H =G IG98 9=H<9F 5G 5 G=B;@9 8FI; CF =B 7CA6=B5
H=CB /5F=CIG .B5B= :CFAI@5H=CBG 5F9 5J5=@56@9 7CBH5=B=B; Withania som-
nifera GI7< 5G <5669 G;5B8 ?IG<H5 ;5C85BH= A5>CCB G5@56 5B8 A5
>CCB N5B>5699@ BCBMACIG  "H =G IG98 :CF H<9 HF95HA9BH C:
DC@M5FH<F=H=G F<9IA5HC=8 5FH<F=H=G @IA65;C D5=B:I@ GK9@@=B;G GD9FA5
HCFF<C95 5GH<A5 @9I7C89FA5 ;9B9F5@ 896=@=HM G9LI5@ 896=@=HM 5BL=9HM
B9IFCG=G G756=9G I@79FG 5B8 @9I7CFF<C95 BCBMACIG $<5F9
'58?5FB= 
-=69H5B GMGH9A C: A98=7=B9 -,& =G CB9 C: H<9 KCF@8G C@89GH ?BCKB
HF58=H=CB5@ GMGH9AG C: A98=7=B9 "H =G DCDI@5F A5=B@M =B BCFH<9FB D5FH
C: "B8=5 =9 %585?< %5<I@ 5B8 ,D=H= 5B8 =G :C@@CK98 6M A7<=G <9F65@
8C7HCFG ,<5<  "H =G 65G98 IDCB H<9 @=H9F5HIF9 C: "B8=5B I8
8<=GH GMGH9A 5B8 =G 5@GC ?BCKB 5G ,CK5+=;D5 K<=7< F9:9FG HC G7=
9B79 C: <95@=B; ,<=885A5@@5MM5 9H 5@  Withania sominifera =G
?BCKB 5G G;5B8B5;CF= ,<5FA5 5B8 $IA5F  CF 58N=;5B8<5
,75FH9NN=B= 5B8 ,D9FCB=  =B -,& "H =G =B8=75H98 A5=B@M :CF
H<9 HF95HA9BH C: F9GD=F5HCFM 8=GCF89F <9
UNCORRECTED PROOF
S. Zahiruddin et al. Journal of Ethnopharmacology xxx (xxxx) xxx-xxx
Fig. 1. &5>CF D<MHC7CBGH=HI9BHG C: G<K5;5B8<5
D5H=7 8=GCF89FG 6C8M GHF9B;H<9B=B; 5B8 A5=BH5=B=B; <9AC;@C6=B @9J9@
!CAC9CD5H<M =G 5 :CFA C: HF58=H=CB5@ A98=7=B9 65G98 CB H<9CFM
C: G=A=@5F=H=9GK<=7< A95BG =: H<9 GI6GH5B79 75IG9G 5BM GMADHCA =B
<95@H<M D9FGCB =H K=@@ 5@GC <95@ H<9 G5A9 GMADHCAG GI779GG=J9@M =B
=@@ D9FGCB "B H<=G GMGH9A CB@M <=;<9F 8=@IH=CBG ?BCKB 5G H=B7HIF9G C:
B5HIF5@ =9 5B=A5@ D@5BHG A=B9F5@G 5B8 GMBH<9H=7 GI6GH5B79G 5F9 DF9
D5F98 :CF HF95H=B; H<9 8=G95G9 ,<=885A5@@5MM5 9H 5@  "H =G
A5=B@M GI;;9GH98 :CF H<9 HF95HA9BH C: @9DFCGM B9FJCIG 8=GCF89FG =BH9GH=
B5@ =B:97H=CB 5B8 F<9IA5H=GA =B !CA9CD5H<M FIB57<5@5A 
"B  %5=8@5K F9DCFH98 H<9 <CAC9CD5H<=7 DFCC: C: Withania somnifera
=B H<9 H<=FH=9H< 79BH9G=A5@ DCH9B7M H<FCI;< 8CI6@96@=B8 D@5796C7CB
HFC@@98 HF=5@ %5=8@5K 
"B <=B5 =H =G ?BCKB 5G "B8=5B ;=BG9B; IFF9BH@M G<K5;5B8<5
:FCA "B8=5 =G BCH 7@5GG=Q98 5G D9F <=B9G9 HF58=H=CB5@ GMGH9A -, A5M
69 8I9 HC =GC@5H=CB 5B8 8=GH5B79 C: 7CIBHF=9G 5B8 H<9=F 7I@HIF9G !CK
9J9F CB H<9 65G=G C: 7CAD5F=GCB 69HK99B J5F=CIG F9@9J5BH <9F6G K=H<
G<K5;5B8<5 =H 75B 69 75H9;CF=N98 =B -, 5G -CB=:M *=5B8 -CB=:M
@CC8 5B8 GG9B79CFA5B 5B8 $9FB5 -<CI;< <=B5 CB H<9
65G=G C: G7=9BH=Q7 F9G95F7< 5B8 9J=89B79G 5F9 ACF9 GI779GG:I@ =B DFCACH
=B; H<9 IG9G C: J5F=CIG <9F6G =B7@I8=B; Withania sominifera )5HK5F8
<5B 9H 5@ 
"B :F=75 Withania somnifera =G H<9 B5H=J9 D@5BH 5B8 A5=B@M 7CB
G=89F98 5G H<9 K998 C: 7CBH5A=B5H98 5B8 K5GH9 5F95G %95J9G 5F9
IG98 5G 8F9GG=B;G :CF =B:97H=CBG 5B8 =BR5AA5H=CBG -<9 FCCH =B H<9 :CFA
C: QB9 DCK89F A=L98 K=H< :5H C: 5B=A5@G 7FC7C8=@9 CF DMH<CB 5B8 =G
IG98 :CF GCF9G 5B8 56G79GG9G 5G C=BHA9BH !IH7<=B;G 9H 5@  "H
=G 5@GC IG98 HC 7CIBH9F57H H<9 :CI@ 6C8M C8CIF -<9 FCCHG 5F9 HF95H98 5B8
IG98 5G 9B9A5G :CF =B:97H=CBG C: H<9 F97HIA 5B8 DMF9L=5 "H =G 5@GC IG98 HC
<95@ F9@5H=CBG<=DG "H =G DF9G7F=698 6M :F=75B HF58=H=CB5@ DF57H=H=CB9FG :CF
:9J9F 7C@8 6FCB7<=5@ 8=GCF89F 5GH<A5 J9B9F95@ =B:97H=CBG GMD<=@=G
8=5FF<95 G?=B 8=G95G9G 5B8 HMD<C=8 "H =G 5@GC =B8=75H98 5G 5BH=<9@A=BH=7
5BH=F<9IA5H=GA G985H=J9 5B8 <MDBCH=7G "B H<9 3I@I HF58=H=CB C: :F=75
Withania somnifera =G IG98 HC DFCH97H D9CD@9 :FCA GCF79FM "H =G 5@GC 5D
D@=98 5G 6CIB85F=9G :CF =BG97HG %5=8@5K 
4. Common brain disorders
-<9 H9FA 6F5=B 8=GCF89F =G BCH F9GHF=7H98 HC A95B =BG5B=HM 5B8 5@
@=98 7CB8=H=CBG C: A9BH5@ 89F5B;9A9BH 6IH 5@GC =B7@I89G HC 79FH5=B 9L
H9BH H<9 9ACH=CB5@ 8=GCF89FG (:H9B H<9 9ACH=CB5@ :57HCFG K<9B 7FCGG
H<9 GH5H9 C: BCFA5@7M ;9H 89F5B;98 HC 697CA9 H<9 GMB8FCA9G C: A9B
H5@ 8=GCF89F "H =G GH5H98 H<5H H<9 6F5=B <5G  6=@@=CB B9IFCBG 5B8
957< C: H<9A 7CBB97H K=H< A5BM CH<9FG HC :CFA 7CAAIB=75H=CB B9H
KCF?G -<9G9 B9FJ9 79@@G <5J9 GD97=5@ >C6G @=?9 H<=B?=B; @95FB=B; F9
A9A69F=B; 5G K9@@ 5G HC G99 <95F 5B8 GA9@@ F5=B 79@@G KCF? @=?9
H=BM :57HCF=9G F979=J9 GIDD@=9G ;9B9F5H9 9B9F;M 7CBGHFI7H 9EI=DA9BH
5B8 ;9H F=8 C: H<9 K5GH9 F5=B 79@@G 5@GC DFC79GG 5B8 GHCF9 =B
UNCORRECTED PROOF
S. Zahiruddin et al. Journal of Ethnopharmacology xxx (xxxx) xxx-xxx
Table 2
/5F=CIG B9IFCDFCH97H=J9 DFCD9FH=9G C: D<MHC7CBGH=HI9BHG C: G<K5;5B8<5 =B DF97@=B=75@ AC89@G
)<MHC7CBGH=HI9BHG -MD9C:GHI8M
)5FH
IG98:CF
=GC@5H=CB CG9" &C89@&9H<C8 "B:9F9B79 +9:9F9B79
0=H<5:9F=B @IH5H<=CB97CB>I;5H9
+
In-vitro +CCHG  μ& &9G9B79D<5@=7B9IFCBG
9LDCG98HC
&)) =B>IFM(!
=B>IFM5B8 α,MBI7@9=B
=B>IFM
'9IFCDFCH97H=J9
GIDDF9GGCL=85H=J9
GHF9GGα,MB
5;;F9;5H=CBJ=5
H<9=B8I7H=CBC:
H<97MHCDFCH97H=J9
)"$A-(+
D5H<K5M
+56<=9H5@

0=H<5:9F=B In-vitro μ& ,!))79@@G5<IA5B
B9IFC6@5GHCA579@@@=B9
HF5BG:97H98K=H<!"/
-5H B;A@5B8
7C7 μ&HC
=B8I798B9IFCHCL=7=HM
+98I7H=CB=B
G97F9H98β5B8
=B8I798
B9IFCHCL=7=HM=B
5AM@C=8DF97IFGCF
DFCH9=B))
D@5GA=8
HF5BG:97H98,!
,2279@@G,!
))
-=K5F=9H5@

0=H<5BC@=89K=H<5BC@=895B8
K=H<5:9F=B
In-vivo +CCHG 5B8 A;?;
=BHF5D9F=HCB95@@M
'=7CH=B9 A;?;
=B8I7987CB8=H=CB98
D@579DF9:9F9B79=BA5@9
5@6=BCA=79
BH=588=7H=J9
F9J9FG=B;
B=7CH=B9=B8I79
7CB8=H=CB98D@579
DF9:9F9B79
IACF99H5@

0=H<5BCB9 In-vivo +CCHG 5B8 A;?; ,-3 A;?;=B>97H98
=BHF579F96FCJ9BHF=7I@5F
HCA5@90=GH5FF5HG
)FCH97H=CB5;5=BGH
CL=85H=J9GHF9GG
5B8=BR5AA5HCFM
7MHC?=B9G-'α
"%β"%
&)
)5B89M9H5@

0=H<5BCB95B8!M8FCLMK=H<5BC@=89
In-silico !=;<6=B8=B;5SB=HM
C: ?75@AC@
5;5=BGH βG97F9H5G9
ACBC5A=B9CL=85G9
5B8D<CGD<C8=9GH9F5G9
BH=@N<9=A9FG CF5<9H5@

0=H<5BC@=89 In-vivo +CCHG  μAC@?; ,DF5;I985K@9MF5HG
K9F99LDCG98HC5
G=AI@5H985@H=HI89C:
 A :H
 AA!;=B5
GD97=5@@M89G=;B98
5B=A5@897CADF9GG=CB
7<5A69FDF9GGIF9
+98I7H=CB=B
B9IFC89;9BF5H=CB
F9GHCF=B;
;@IH5H<=CB9
89D@9H=CB5B8
=B7F95G9=B
;@IH5H<=CB9
6=CGMBH<9G=G
H<FCI;<'F:
D5H<K5M6M
IDF9;I@5H=CBC:
%@9J9@=B
B9IFCB5@79@@G
7CFH=7CGH9FCB9
89D9B89BH
A5BB9F
5=H<5FI9H5@

In-vitro μ;A@ @=CA5F5H5B8
B9IFCB5@"&+
<IA5B79@@@=B9G
5;5=BGHG7CDC@5A=B9
 A&=B8I798HCL=7=HM
+9;I@5H=CBC:
B9IFCB5@79@@
A5F?9FG'!
&)),
)5B8;@=5@
79@@A5F?9F )
5B8K=H<
IDF9;I@5H=CBC:
'85A5;9
γ!15B8
CL=85H=J9GHF9GG
+(,A5F?9FG
$CB5F9H5@

UNCORRECTED PROOF
S. Zahiruddin et al. Journal of Ethnopharmacology xxx (xxxx) xxx-xxx
Table 2 Continued
)<MHC7CBGH=HI9BHG -MD9C:GHI8M
)5FH
IG98:CF
=GC@5H=CB CG9" &C89@&9H<C8 "B:9F9B79 +9:9F9B79
In vitro +CCHG μ& β=B8I798HCL=7=HM=B
Caenorhabditis elegans
%KCFAG
+9J9FG98H<9
DCH9BH=5@C:β
:C@@CK986M
579HM@7<C@=B95B8
579HM@
7<C@=B9GH9F5G9
AC8I@5H=CB
F9GI@H=B;
B9IFCDFCH97H=CB
?<CCB9H5@

In-silico %=;5B8=BH9F57H=CBK=H<
H<9F9G=8I9G-<F
-FD,9F5B8
!=GC:<IA5B579HM@
7<C@=B9GH9F5G9
C7?=B;
G=AI@5H=CBF9GI@HG
=B<=;<6=B8=B;
5SB=HMC:H<9
@=;5B8HCH<9
F979DHCF
FCJ9F9H5@

In vitro +CCHG μ& LCB5@5B889B8F=H=7
5HFCD<MK5G=B8I798=B
7I@HIF98F5H7CFH=75@
B9IFCBG6MHF95HA9BH
K=H<5AM@C=8
β μ&
+9;9B9F5H=CBC:
B9IF=H=G
F97CBGHFI7H=CBC:
GMB5DG9G6CH<DF9
5B8DCGH=B
B9IFCBG
$I6CM5A59H
5@
in vivo +CCHG  μAC@?;85M
CF5@@M
05H9FA5N9H9GH&5@9
882A=79
+97CJ9F98
A9ACFM89:97HG
0=H<5BC@=89G5B8K=H<5BCG=89G In vivo ;?;CF5@@M ))),@N<9=A9FG
8=G95G9HF5BG;9B=7A=79
+9J9FG9G
9<5J=CF5@
9Q7=HG5B8
D@5EI9D5H<C@C;M
897F95G9Gβ
@9J9@G5B8
DFCACH9G
8=G5;;F9;5H=CBC:
(@=;CA9FG
57H=J5H98
A=7FC;@=5
DFCL=A5@HCH<9
D@5EI9G897F95G9
G=;B=Q75BH@M
9B<5B79G%+)5B8
')A+'5B8
8CKBF9;I@5H=CB
C:<9D5H=7%+)
,9<;5@9H5@

0=H<5BC@=89G"/5B8/ ,D97HFCD<CHCA9HF=7
5B8 In silico 5B8 μ&
579HM@7<C@=B9GH9F5G9G
5B85B8 μ&
6IHMFM@7<C@=B9GH9F5G9
9H9FA=B5H=CBC:?=B9H=7
D5F5A9H9FGAC@97I@5F
8C7?=B;GD5GAC@MH=7
5B875@7=IA5BH5;CB=GH
57H=J=H=9G
0=H<5BC@=89"/
5F9BCB
7CAD9H=H=J9
=B<=6=HCFC:<
5B8<
0=H<5BC@=9/5F9
@=B95FA=L98HMD9
=B<=6=HCFC:<
!=;<6=B8=B;
5SB=HM:CF<
L<=6=HG
GD5GAC@MH=75B8
75@7=IA
5BH5;CB=GH=7
DCH9BH=5@
<CI8<5FM9H
5@
UNCORRECTED PROOF
S. Zahiruddin et al. Journal of Ethnopharmacology xxx (xxxx) xxx-xxx
Table 2 Continued
)<MHC7CBGH=HI9BHG -MD9C:GHI8M
)5FH
IG98:CF
=GC@5H=CB CG9" &C89@&9H<C8 "B:9F9B79 +9:9F9B79
0=H<5BC@=89# &'
K=H<5:5GHICG=B5B8GCAB=:9F=B9
In silico )CH9BH=5@=B<=6=H=CBC:
;9@5H=B5G9GA5=B@M
A9H5@@CDFCH9=B5G9=9
&&)5B8&&)=B
7CAD5F=GCBK=H<DCH9BH
;9@5H=B5G9=B<=6=HCFG=9
<M8FCL5A=757=8
8CLM7M7@=B9
A=BC7M7@=B9EI9F79H=B
5B8F9J9FG9
<M8FCL5A5H9
"B<=6=H=CBC:
;9@5H=B5G9G
&&)
-<9F5D9IH=75@@M
57H=J9=B=G7<9A=7
GHFC?9
<9ACFF<5;=7
GHFC?95B8
D9F=B5H5@<MDCL=7
$IA5F5B8
)5HB5=?

0=H<5BC@=895EI9CIG:F57H=CB In-vivo +CCHG 5B8
 A;?;CF5@@M
!MDCL=5H=A9
5BH=:5H=;I99T97H
GK=AA=B;D9F:CFA5B79
H=A9GK=AA=B;
=B8I798;5GHF=7
I@79F5H=CB5B8
<MDCH<9FA=5
=AAC6=@=N5H=CB=B8I798
;5GHF=7I@79F5H=CB
5IHC5B5@;9G=5
BH=GHF9GG57H=J=HM
=B8CG989D9B89BH
A5BB9F
,=B;<9H5@

0=H<5BCB9 In-vitro  μ&  μ&F9H=BC=7=B8I798
B9IFCB5@8=GHCFH=CBCB
'9IFC'5ACIG9
B9IFC6@5GHCA579@@@=B9
:C@@CK986MA&
'&
'9IFCDFCH97H=J9
9T97HGC:
0=H<5BCB9
:C@@CK986M
F98I7H=CB=B
CL=85H=J9GHF9GG
5B8DFC5DCDHCH=7
7MHC?=B9G
5F9H5@

,H=;A5GH9FC@0=H<5:9F=B5B8
K=H<5BC@=89 5B8
In silico "B<=6=H=CB9S7=9B7M
5;5=BGHDC@M)
F=6CG9DC@MA9F5G9
))+=B7CAD5F=GCB
HCDCH9BH=B<=6=HCFG
+)#5B8
H5@5NCD5F=6
!=;<6=B8=B;
5SB=HM:CF
75H5@MH=78CA5=B
)+)5B8
69B9Q7=5@=B
B9IFC7MHCHCL=7=HM
5B8CH<9F
B9IFC@C;=75@
8=GCF89FG@=?9
GHFC?99H7
&I?<9F>999H
5@
@M7CK=H<5BC@=89GG=HC=B8CG=89"15B8
G=HC=B8CG=891
In-vivo +CCHG  A;?;CF5@@M +9GHF5=BHGHF9GG=B8I798
;5GHF=7I@79FG=B5@6=BC
F5HGD5GG=J95JC=85B79
H9GHF979=J=B;5:CCH
G<C7? G A
9@97HF=77IFF9BH=B
5@6=BCF5HG
BH=GHF9GG5B8
=ADFCJ9A9ACFM
5B8@95FB=B;
9BHF5@
GH=AI@5H=CB
7<5F57H9F=N986M
D=@C9F97H=CB
=B7F95G98ACH=@=HM
F957H=J=HMHC
GH=AI@=
GDCBH5B9CIG
ACHCF57H=J=HM5B8
5I;A9BH98
@95FB=B;
57EI=G=H=CB
<CG5@9H5@

@M7CK=H<5BC@=89G In vivo +CCHG 5B8 A;
?;CF5@@M
@9J5H98D@IGA5N9H9GH
,C7=5@=BH9F57H=CB5B8
:998=B;@5H9B7M=B5B
IB:5A=@=5F9BJ=FCBA9BH
BH=5BL=9HM
F98I798HF=6I@=B
@9J9@G=BF5H6F5=B
5B8
BH=89DF9GG5BH
9T97H
<5HH57<5FM5
9H5@
UNCORRECTED PROOF
S. Zahiruddin et al. Journal of Ethnopharmacology xxx (xxxx) xxx-xxx
Table 2 Continued
)<MHC7CBGH=HI9BHG -MD9C:GHI8M
)5FH
IG98:CF
=GC@5H=CB CG9" &C89@&9H<C8 "B:9F9B79 +9:9F9B79
0=H<5BC@=89 In silico )CH9BH5B8G9@97H=J9
=B<=6=HCFC:B9IFCB5@
B=HF=7CL=89GMBH<5G9
B'(,5B8'(,CB
H<965G=GC:G9@97H=J=HM
6=B8=B;9B9F;M5B8
=BH9F57H=CBDFCQ@9
I5@G9@97H=J9
=B<=6=H=CBC:6CH<
B'(,='(,5B8
9'(,
)CH9BH=5@
B9IFCH<9F5D9IH=7
5;9BHA5=B@M:CF
8=GCF89FG
A98=5H986M
B'(,57H=J5H=CB
$IA5F9H5@

0=H<5B5A=89G5B8K=H<5BC@=89G &C89@GMGH9AIG=B;
@5F;9IB=@5A9@@5F
J9G=7@9G
FI=HG 5B8 μ;A@ 9  =B8I798@=D=8
D9FCL=85H=CB5GG5M5B8
)! =B8I798@=D=8
D9FCL=85H=CB5GG5M
"B<=6=HG@=D=8
D9FCL=85H=CB5BH=
CL=85BH
#5M5DF5?5G5A
9H5@
0=H<5B5A=895B8 In vitro FI=HG  μ;A@ +5HB9IFCB5@79@@G=9
) 79@@G79@@
J=56=@=HM5GG5M5B8
AC@97I@5FAC89@=B;
GHI8=9G'&+
)FCH97H
) 79@@G:FCA
79@@85A5;9
=B8I796M β
5AM@C=8
"B<=6=HQ6F=@
:CFA5H=CB6=B8HC
57H=J9G=H9C: β
5AM@C=8
#5M5DF5?5G5A
9H5@
:CFA5H=CB HC 7CAAIB=75H9 K=H< CH<9F 79@@G -<9 @5F;9 5ACIBH C: :I9@ 5B8
CLM;9B =G F9EI=F98 :CF DFCD9F :IB7H=CB=B; 5B8 7CCF8=B5H=CB -<9 7CA
ACB 6F5=B 8=GCF89F =G 7C@@5H98 =B =; -<9 =B:CFA5H=CB F9@5H98 HC 8=:
:9F9BH GHI8=9G 7CB8I7H98 CB G<K5;5B8<5 9LHF57HG 5F9 GIAA5F=N98 =B
-56@9
4.1. Ashwagandha in anxiety
BL=9HM =G 89QB98 5G 5B 9ACH=CB 7<5F57H9F=N98 6M :99@=B;G C: H9B
G=CB KCFF=98 H<CI;<HG 5B8 D<MG=75@ 7<5B;9G (J9F7CBGIADH=CB C: H5GHM
5B8 <=;<75@CF=9G :CC8 =G F9GDCBG=6@9 :CF 7<FCB=7 DCG=H=J9 9B9F;M 65@5B79
K<9F9 H<9 =B;9GH=CB C: 9B9F;M 9L7998G 9B9F;M 9LD9B8=HIF9 75IG9 HC 9L
HF5 :5H =B 6C8M K9=;<H ;5=B 5B8 C69G=HM =B< 9H 5@  -<9 =B;9G
H=CB C: <=;<75@CF=9 :CC8 <5G 5@GC 699B 5GGC7=5H98 HC J5F=CIG B9IFCDGM
7<=5HF=7 8=GCF89FG @=?9 5BL=9HM ACC8 8=GCF89FG 5B8 6=B;9 95H=B; 5G
H5BCB 9H 5@ 
)CK89F 9LHF57H C: G<K5;5B8<5 @95: GHI8=9G GI;;9GH H<5H =H <5G
5BH=5BL=9HM 5BH==BR5AA5HCFM 5B8 5BH=5DCDHCH=7 DFCD9FH=9G K<=7<
A5M 69 F97CAA9B898 HC DF9J9BHG@CK 8CKB H<9 58J9FG9 9::97HG C: C69
G=HM 5B8 =HG 5GGC7=5H98 8=G95G9 $5IF 5B8 $5IF 
-<9 <M8FC 5@7C<C@=7 9LHF57H C: FCCHG C: G<K5;5B8<5 F9DCFH98 G=;B=:
=75BH 5BH=GHF9GG 57H=J=HM ,=B;< 9H 5@  @7C<C@=7 9LHF57H C: G<
K5;5B8<5 FCCH 5B8 G998 K5G ;=J9B HC A=79  A;?; =BHF5 D9F=HCB95@
5G 5 G=B;@9 8CG9 5B8 C6G9FJ98 GK=AA=B; D9F:CFA5B79 "H K5G C6G9FJ98
H<5H H<9 GK=AA=B; H=A9 C: G<K5;5B8<5 HF95H98 A=79 8CI6@98 5G 7CA
D5F98 HC BCFA5@ 7CBHFC@ "H GI;;9GH H<5H G<K5;5B8<5 =B8I798 5 GH5;9 C:
BCBGD97=Q7 =B7F95G98 F9G=GH5B79 8IF=B; GHF9GG 7CB8=H=CB &=G<F5 9H 5@
,=B;< 9H 5@ 
G<K5;5B8<5 <5G 5 G=;B=:=75BH 5BH=GHF9GG 585DHC;9B=7 9::97H 5G F9
DCFH98 6M 5G=7 &98=75@ ,7=9B79G 5H 5@7IHH5 .B=J9FG=HM -<9M GHI8
=98 H<9 9::97H C: G<K5;5B8<5 CB 7<FCB=7 GHF9GG =B FC89BHG B 9@97
HF=7 :CCH G<C7? F979=J98 :CF 5 D9F=C8 C:  85MG DFC8I798 <MD9F;@M
Fig. 2. CAACB 6F5=B 8=GCF89FG
UNCORRECTED PROOF
S. Zahiruddin et al. Journal of Ethnopharmacology xxx (xxxx) xxx-xxx
Table 3
+9DCFH98 GHI8=9G C: G<K5;5B8<5 9LHF57HG =B7@I8=B; 8CG9 A97<5B=GA 5B8 A9H<C8 9AD@CM98 HC <=;<@=;<H =HG FC@9 =B 6F5=B F9@5H98 8=GCF89FG
LHF57H CG9 &97<5B=GA=BJC@J98 &9H<C8 "B:9F9B79 +9:9F9B79
H<5BC@=7FCCH
9LHF57HC:
G<K5;5B8<5
 A;?;CF5@@M "ADFCJ9A9BH=B=AD5=F98GD5H=5@
A9ACFM5B8CL=85H=J9GHF9GG
AC8I@5H=CBC:&@9J9@G+(,
,(5B875H5@5G9
,=;B=Q75BH=B7F95G9=B'&
F979DHCF9LDF9GG=CB
=GD<9BC@ μ;?;=B>97H98CF5@@M:CF
85MGHCA5@9,K=GG5@6=BCA=79
'9IFCDFCH97H=J9
5B85BH=CL=85BH
=ADFCJ9G
7C;B=H=J9
=AD5=FA9BH
=F@59H5@

EI9CIG@95J9G
9LHF57HC:
G<K5;5B8<5
 A;?;CF5@@M "ADFCJ9A9BH=B@C7CACHCF
7CCF8=B5H=CBKCF?=B;A9ACFM5B8
@95FB=B;:IB7H=CBG
'CFA5@=N5H=CB=B9LDF9GG=CBC:
GMB5DH=7D@5GH=7=HMA5F?9FG
+9GHCF5H=CBC:G=;B5@=B;DFCH9=BG
'-F?)%γ")+5B8)"$
?H
%), A;?;=B>97H98=BHF5D9F=HCB95@@MHC
A5@90=GH5F5@6=BCF5HG:CFK99?G
9<5J=CIF5@GHI8=9GFCH5FC8H9GHB5FFCK
695AK5@?H9GHBCJ9@C6>97HF97C;B=H=CBH9GH
HH9BI5H=CBC:
B9IFC=BR5AA5H=CB
5B8
B9IFC89;9B9F5H=CB
IDH55B8
$5IF
EI9CIG
GIGD9BG=CBC:
G<K5;5B8<5
 A;?;CF5@@M "ADFCJ9A9BH=B57EI=G=H=CBG5B8
F9H9BG=CB=BGH9D8CKB@5H9B7MH9GH
+9J9FG9CL=85H=J9GHF9GG6M
5HH9BI5H=B;9T97HC:8=9@8F=BCB
&@9J9@DFCH9=B75F6CBM@5B8
F98I798;@IH5H<=CB957H=J=HM
=9@8F=B
A;?;=B8I798AC8I@5H=CBC:7C;B=H=J9
:IB7H=CB5B8CL=85H=J9GHF9GG=BA5@90=GH5F
F5H
'9IFCDFCH97H=J9
5B85BH=CL=85BH
<CG<9H5@

+CCH9LHF57HC:
G<K5;5B8<5
5B8 A;A@
CF5@@M
+9;I@5H=CBC:CD=C=8F979DHCFG
&ICD=C=8&()5B8BC7=79DH=B
'();9B99LDF9GG=CB=B,!
,2279@@G
 μ&ACFD<=B9 μ&B5@CLCB9=B8I798
HCL=7=HMCB<IA5B,!,22B9IFC6@5GHCA5
79@@G
)F9J9BH=CBC:
ACFD<=B99@=7=H98
;9B99LDF9GG=CB
5@H9F5H=CB
&C8I@5H=CBC:
&()5B8'()
9LDF9GG=CB
5DIH=9H5@

EI9CIG9LHF57H
C:G<K5;5B8<5
 A;?;CF5@@M "B<=6=H98H<975GD5G9=B89D9B89BH
A97<5B=GAC:5DCDHCG=G6MH<9
=B<=6=H=CBC:DC@M)F=6CG9
DC@MA9F5G95B8=ADFCJ95BH=
CL=85BH9BNMA9
<9ACLM;9B5G9!(
)9FA5B9BHA=88@979F96F5@5FH9FMC77@IG=CB
D&(
'9IFCDFCH97H=J9
9T97H
+5;<5J5B
5B8,<5<

G<K5;5B8<5
5EI9CIG
GIGD9BG=CB
 A;?;CF5@@M HH9BI5H=CBC:<=B<=6=H=CB
=ADFCJ9A9BH=B7C;B=H=J9
=AD5=F9A9BH
)FCDCLIF5H8CG9C: A;?;8=GGC@J98=B
C@=J9C=@58A=B=GH9F98HCK=GH5F5@6=BCF5HG
BH=@N<9=A9FG 2585J9H5@

&9H<5BC@
<@CFC:CFA
9LHF57HC:
5G<K5;5B8<5
'9IHF5@=N5H=CBC:HCL=79T97HG
GIDDCFH986M&--79@@J=56=@=HM
5GG5MG5B8H<9D9FCL=GCA9
DFC@=:9F5HCF57H=J5H98F979DHCFγ
))+γ@9J9@G
β5AM@C=8=B8I798HCL=7=HM5B8!"/5
%7@589=B:97H=CBIG=B;5<IA5BB9IFCB5@
,$'&79@@@=B9
BH=@N<9=A9FG $IF5D5H=9H
5@
H<5BC@=7
9LHF57H
C: G<K5;5B8<5
 A;?;CF5@@M "ADFCJ9A9BH=BCL=85H=J9GHF9GG
DFCQ@9F9GHCF5H=CBC:69<5J=CF5@
D9F:CFA5B79
A9H<M@D<9BM@H9HF5<M8FCDMF=8=B9
&)-)=B8I798)5F?=BGCB@=?9GMADHCAG=B
5@67A=79
BH=)5F?=BGCBG <5HB5;5F9H
5@
H<5BC@=7
9LHF57H
C: G<K5;5B8<5
 A;?;CF5@@M "ADFCJ9A9BH=BH<9ACHCF
ACJ9A9BHD5HH9FBG5B8;F=DD=B;
56=@=HMF9GHCF5H=CBC:HMFCG=B9
<M8FCLM@5G9-!=AAIBCGH5=B=B;
=BGI6GH5BH=5B=;F55B8AC8I@5H=CB
C:5DCDHCH=7A97<5B=GAH<IG
=ADFCJ9A9BH=B69<5J=CIF5@
D9F:CFA5B79
&5B96 A;?;5B8)5F5EI5H A;?;
=B8I79)5F?=BGCB=GA=BGK=GG5@6=BCA=79
BH=)5F?=BGCBG )F5?5G<9H
5@
)F5?5G<9H
5@
G<K5;5B8<5
FCCH9LHF57H
BF=7<988=9H "ADFCJ9A9BH=B@C7CACHCF
:IB7H=CBAC8I@5H=CBC:CL=85H=J9
GHF9GG5B8BCFA5@=N9C:@9J9@GC:
GI77=B5H989<M8FC;9B5G9&--
A9A6F5B96CIB89BNMA9GJ=N
'!7MHC7<FCA97F98I7H5G95B8
GI77=B5H97MHC7<FCA97F98I7H5G9
+CH9BCB9=B8I798@C7CACHCF89Q7=HG
CL=85H=J9=AD5=FA9BHG5B8B9IFCHCL=7=HM
=B Drosophila melanogaster
'9IFCAC8I@5HCF
5B8BH=
)5F?=BGCBG
&5B>IB5H<
5B8
&IF5@=8<5F5

G<K5;5B8<5
FCCH9LHF57H
 A;?;CF5@@M "B7F95G9=B@9J9@GC:8CD5A=B9
8=<M8FCLMD<9BM@579H=757=8
5B8<CACJ5B=@@=757=8
BCFA5@=N5H=CBC:@=D=8D9FCL=85H=CB
A5F?9F
A9H<M@D<9BM@H9HF5<M8FCDMF=8=B9
&)-)5H8CG9C: A;?;HCA5@9,K=GG
5@6=BCA=79
BH=)5F?=BGCBG +5>5G5B?5F
9H5@5
UNCORRECTED PROOF
S. Zahiruddin et al. Journal of Ethnopharmacology xxx (xxxx) xxx-xxx
Table 3 Continued
LHF57H CG9 &97<5B=GA=BJC@J98 &9H<C8 "B:9F9B79 +9:9F9B79
G<K5;5B8<5
@95J9G9LHF57H
 A;?;CF5@@M "ADFCJ9A9BH=BDCGHIF95B8H<9
7CCF8=B5H98ACHCFG?=@@G=B7@I8=B;
JC@IBH5FMACJ9A9BHGK5@?=B;5B8
F98I798GHF=89@9B;H<
A9H<M@D<9BM@H9HF5<M8FCDMF=8=B9
&)-)5H8CG9C: A;?;HCA5@9,K=GG
5@6=BCA=79
BH=)5F?=BGCBG +5>5G5B?5F
9H5@
6
G<K5;5B8<5
FCCH9LHF57H
 A;?;CF5@@M "ADFCJ9A9BH=BH<9A=79G69<5J=CIF
BCFA5@=N5H=CB=BGID9FCL=89
8=GAIH5G95B875H5@5G9
A9H<M@D<9BM@H9HF5<M8FCDMF=8=B9
&)-)5H8CG9C: A;?;HCA5@9,K=GG
5@6=BCA=79
BH=)5F?=BGCB +5>5,5B?5F
9H5@

G<K5;5B8<5
FCCH9LHF57H
5B8 A;?;CF5@@M 'CFA5@=N5H=CBC:@=D=8D9FCL=85H=CB
5B8B=HF=H95B8@57H5H989<M8FC;9B5G9
9BNMA9@9J9@G
"B<=6=H6@C7?589=B-)GMBH<9G=G6M
=B<=6=H=B;H<9A=HC7<CB8F=5@7CAD@9L
57H=J=HM=BH<98=T9F9BHF9;=CBG
GHF=5HIA5B87CFH9L
'=HFCDFCD=CB=757=8 A;?;:CF85MG
"BHF5D9F=HCB95@HCF5H
BH=!IBH=B;HCBG
8=G95G9
$IA5F5B8
$IA5F

G<K5;5B8<5
FCCH9LHF57H
5B8 A;?;CF5@@M "ADFCJ9A9BH=B7C;B=H=J9=AD5=FA9BH
=B&CFF=GK5H9F5B8D@IGA5N9H9GHG
5B8F9GHCF98 ,!HCH5@;@IH5H<=CB9
CL=8=N98;@IH5H<=CB9 ,-5B8
5HH9BI5H98579HM@7<C@=B9GH9F5G9@9J9@G
'=HFCDFCD=CB=757=8 A;?;:CF85MG
"BHF5D9F=HCB95@HCF5H
'9IFCAC8I@5H=CB $IA5F5B8
$IA5F

G<K5;5B8<5
;<FIH<5:5H
9LHF57H
5B8 A;?;CF5@@M "B<=6=H=CBC:=AAC6=@=HMH=A9
BH5;CB=GAC:DHCG=G75H5HCB=55B8
G985H=CB
CF798GK=AH9GH5B8H5=@GIGD9BG=CBH9GH
+9G9FD=B9=B8I798DHCG=G75H5HCB=55B8
G985H=CB
BH=89DF9GG5BHG #5M5BH<=

)IF9DCK89F
C:
G<K5;5B8<5
5B8 A;?;CF5@@M "B7F95G9=B5JC=85B79F9GDCBG9
9G75D9:5=@IF95B8=AAC6=@=HMD9F=C8
@6=BCF5HGGI6>97H98HC9@97HF=7G<C7?=B
@95FB98<9@D@9GGB9GGH9GH5B8GK=AA=B;=B
:CF798GK=AA=B;H9GH
BH=89DF9GG5BHG &5=HM9H
5@
EI9CIG
9LHF57HC:
G<K5;5B8<5
FCCH
5B8 A;?;CF5@@M "ADFCJ9869<5J=CF5@5@H9F5H=CBG
5@H9F98CL=85H=J9GHF9GGA5F?9FG5B8
F9GHCF98<=GHC5F7<=H97HIF9C:
79F969@@IA
,C8=IAJ5@DFC5H9 A;?;GI67IH5B9CIG
=B%7A=79
BH=5IH=GA /99F9G<9H
5@
&9H<5BC@=7
9LHF57HC:
G<K5;5B8<5
FCCH
 A;?;CF5@@M )F9J9BH=CB=B6CH<ACFD<=B95B8
9H<5BC@9@=7=H98=B7F95G9GC:
8CD5A=B9=BH<9G<9@@C:H<9BI7@9IG
577IA69BG
&CFD<=B95B89H<5BC@=B8I79=B7F95G9=B
8CD5A=B9=BA5@9,DF5;I985K@9MF5H
&CH=J5H98
69<5J=CF5@
5@H9F5H=CBG
5GG5F9C
9H5@

G<K5;5B8<5
9LHF57H
 A;
?;=BHF5D9F=HCB95@
+9J9FG=B;B=7CH=B9=B8I79
7CB8=H=CB98D@579DF9:9F9B79
'=7CH=B9 A;?;=B8I7987CB8=H=CB98D@579
DF9:9F9B79=BA5@95@6=BCA=79
BH=588=7H=J9 IACF99H
5@
G<K5;5B8<5
9LHF57H
A;=B μ%GH9F=@9
6IT9F98G5@=B9
+98I7H=CB=B@9J9@GC:A=G:C@898
,(5B8C:D<CGD<CFM@5H98'κ
-F5BG;9B=7%A=79 75FFM=B;
 GC8 AIH5BH
BH=5AMCHFCD<=7
@5H9F5@G7@9FCG=G
IHH59H
5@
G<K5;5B8<5
FCCH9LHF57H
 A;?;CF5@@M A9@=CF5H=CBC:J57ICIG7<9K=B;
ACJ9A9BHG5B8HCB;I9DFCHFIG=CBG
F9J9FG98H<9897F95G9=B:CF96F5=B
,(
!5@CD9F=8C@ A;?;=D;=J9B
7<FCB=75@@MHCA5@90=GH5FF5HGHC=B8I79CF5@
8MG?=B9G=5G
BH=CL=85BH
"B<=6=H
B9IFC89;9B9F5H=CB
'5=8I9H
5@
G<K5;5B8<5
FCCH9LHF57H
5B8 A;?;
CF5@@M
"ADFCJ9A9BH=B8=GFIDH=CBC:
57EI=G=H=CB5B8F9H9BH=CB
+98I798H<9@5H9B7MHCF957<H<9
G<C7?:F99NCB9
"ADFCJ98A9ACFM7CBGC@=85H=CB
,7CDC@5A=B9 A;?;58A=B=GH9F98
=BHF5D9F=HCB95@HC@6=BCA=79
7IH9HF95HA9BHK=H<9@97HFC7CBJI@G=J9
G<C7?=AA98=5H9@M5:H9FHF5=B=B;
<FCB=7HF95HA9BHK=H<9@97HFC7CBJI@G=J9
G<C7?:CFGI779GG=J985MG5H <=BH9FJ5@G
'CCHFCD=79T97H
5B85BH=5AB9G=5
<I@9M

UNCORRECTED PROOF
S. Zahiruddin et al. Journal of Ethnopharmacology xxx (xxxx) xxx-xxx
759A=5 ;@I7CG9 =BHC@9F5B79 ;5GHF=7 I@79F5H=CBG A5@9 G9LI5@ 8MG:IB7
H=CB 7C;B=H=J9 89Q7=HG =AAIBCGIDDF9GG=CB 5B8 A9BH5@ 89DF9GG=CB =B
5B=A5@G -<9 9LHF57H C: G<K5;5B8<5 5B <CIF 69:CF9 H<9 G<C7? F98I798
GHF9GG @9J9@ G=;B=:=75BH@M ,=B;< 9H 5@  G<K5;5B8<5 897F95G98
B9IFCB 57H=J=HM 5B8 =B<=6=H98 B9FJ9 79@@G :FCA CJ9F QF=B; G<K5;5B8<5
DFC8I79G  HMD9 57H=J=HM K<=7< A5M =B8=75H9 =H <5G 5BH=5BL=9HM 57
H=J=HM ,=B;< 9H 5@ 
4.2. Ashwagandha in Alzheimer's
@N<9=A9FG 8=G95G9 =G 89QB98 5G B9IFC89;9B9F5H=J9 8=G95G9 A5=B@M
7<5F57H9F=N98 6M DFC;F9GG=J9 A9ACFM @CGG 5B8 =FF9J9FG=6@9 897@=B9 =B
7C;B=H=J9 :IB7H=CBG /5F=CIG in vitro 5B8 in vivo GHI8=9G <=;<@=;<H98 H<9
9::97H C: G<K5;5B8<5 5B8 =HG D<MHC7CBGH=HI9BHG =B @N<9=A9FG 8=GCF89F
+979BH@M H<9 F9G95F7< K5G 7CB8I7H98 HC 9J5@I5H9 H<9 5BH= @N<9=A9FG
7CBGH=HI9BH DF9G9BH =B H<9 FCCH 9LHF57H C: G<K5;5B8<5 5B8 7CB7@I898
H<5H 0=H<5BCB9 G<CKG G=;B=:=75BH 57H=J=HM GD97=:=75@@M 6M =B<=6=H=CB C:
5AM@C=8 β 0=H<5BCB9 5@GC :CIB8 HC =BH9BG=:M H<9 57H=J=HM C: 579HM@
7<C@=B9 ;@IH5H<=CB9 5B8 G97F9H5G9 9BNMA9 β5B8 γ 5B8 =ADFCJ98 H<9
9@9J5H=CB =B DFC=BR5AA5HCFM 7MHC?=B9G @9J9@G )5B89M 9H 5@ 
0=H<5BC@=89 =B<=6=H98 <IA5B 579HM@ 7<C@=B9GH9F5G9 6M <=;< 6=B8=B;
5SB=HM DF98=7H98 6M 8C7?=B; G=AI@5H=CB GHI8=9G FCJ9F 9H 5@ 
"B 9LD9F=A9BH5@ GHI8=9G D9F:CFA98 6M ,9<;5@ 9H 5@ G9A= DIF=Q98 FCCH
9LHF57H C: G<K5;5B8<5 A5=B@M 7CBH5=B=B; K=H<5BC@=89G 5B8 K=H<5BC
G=89G K<=7< F9J9FG98 @N<9=A9FG 8=G95G9 6M DFC8I7=B; B9IFCDFCH97H=J9
9::97HG 5;5=BGH !( 5B8 β AM@C=8 7MHCHCL=7=HM =B ))), HF5BG;9B=7
A=79 5B8 )),K@B8 A=79 @=B9 # C: @N<9=A9FG 8=G95G9 6M IDF9;
I@5H=CB C: @=DCDFCH9=B F979DHCFF9@5H98 DFCH9=B =B @=J9F ,9<;5@ 9H 5@

G<K5;5B8<5 5H 8CG9 C:  A;?; G<CKG 9B9FJ5H=CB C: < =B<=
6=H=CB 5B8 7C;B=H=J9 =AD5=FA9BH H<IG G<CK=B; DFCH97H=J9 9::97HG 5;5=BGH
DFCDCLIF 9LDCGIF9 =B F5HG 2585J 9H 5@  &9H<5BC@=7 7<@CFC:CFA
9LHF57H C: G<K5;5B8<5 9@=7=HG <=;< 79@@ J=56=@=HM 5B8 9B<5B79G ))+7
@9J9@G 5@CB; K=H< F9GHCF5H=CB =B ACFD<C@C;M C: 79@@ 5;5=BGH ,$'& 79@@
@=B9 =B:97H98 6M β5AM@C=8 $IF5D5H= 9H 5@  IFH<9FACF9 5EI9
CIG 9LHF57H C: G<K5;5B8<5 7CBH5=B=B; 0=H<5BC@=89 89F=J5H=J9G =B7@I8
=B; K=H<5:9F=B G<CKG DCH9BH=5@ DFCH97H=CB =B 8=::9F9BH=5H98 D<9C7<FC
AC7MHCA5 ) 79@@G =B:97H98 6M <M8FC;9B D9FCL=89 5B8 β7MHCHCL=7=HM
$IA5F 9H 5@ 
4.3. Ashwagandha in Parkinson's
)5F?=BGCBG 8=G95G9 =G 5 DFC;F9GG=J9 5;989D9B89BH B9IFC89;9B9F
5H=J9 8=GCF89F DF=A5F=@M 7<5F57H9F=N98 6M 89D@9H=CB C: 8CD5A=B9F;=7
GI6GH5BH=5 B=;F5 B9IFCBG 75IG98 6M ;9B9H=7 5B8 9BJ=FCBA9BH5@ :57HCFG
"H =G 5GGC7=5H98 K=H< CL=85H=J9 GHF9GG A=HC7<CB8F=5@ 8MG:IB7H=CB 5B8
56BCFA5@=HM =B 5;;F9;5H=CB C: DFCH9=B G<K5;5B8<5 <5J9 699B 9L
D@CF98 =B J5F=CIG GHI8=9G HC 5A9@=CF5H9 )5F?=BGCBG 8=GCF89F G<K5
;5B8<5 9H<5BC@=7 FCCH 9LHF57H <5G 699B :CIB8 HC F9J9FG9 H<9 )5F?=B
GCB@=?9 GMADHCAG =B &)-) =B8I798 )5F?=BGCB =B 5@67 A=79 <5HB5
;5F 9H 5@  G<K5;5B8<5 7CB:9FF98 =AD5=F98 7<C@=B9F;=7 :IB7
H=CB 5B8 89D@9H=CB =B 8CD5A=B9 @9J9@G =B FCH9BCB9 AC89@ C: Drosophila
melanogaster 6M GIDDF9GG=CB C: CL=85H=J9 GHF9GG 5B8 A=HC7<CB8F=5@ 8MG
:IB7H=CBG &5B>IB5H< 5B8 &IF5@=8<5F5  &CIG9 K<9B HF95H98
K=H< A9H<M@D<9BM@H9HF5<M8FCDMF=8=B9 G<CK98 5@H9F5H=CB =B
75H97<C@5A=B9G 5BH=CL=85BHG 5B8 @=D=8 D9FCL=85H=CB A5F?9F @9J9@ -F95H
A9BH K=H<  A;?; C: G<K5;5B8<5 @958G HC BCFA5@=N=B; 8CD5A=B9
8=<M8FCLMD<9BM@579H=7 57=8 <CACJ5B=@@=7 57=8 5BH=CL=85BHG ;@I
H5H<=CB9 5B8 ;@IH5H<=CB9 D9FCL=8=G9 5B8 H<=C65F6=HIF=7 57=8 F957H=J9
GI6GH5B79 @9J9@G =B GHF=5HIA 5B8 =ADFCJ9A9BH =B ACHCF :IB7H=CBG +5
>5,5B?5F 9H 5@ 56
BCH<9F GHI8M 7CB8I7H98 =B  =B8=75H98 =ADFCJ9A9BH =B A=79
69<5J=CIF 5BH=CL=85BH GH5HIG 5B8 @=D=8 D9FCL=85H=CB @9J9@G =B H<9
6F5=B C: )5F?=BGCBG =B8I798 A=79 +5>5,5B?5F 9H 5@  )F5?5G<
9H 5@ =B  89ACBGHF5H98 H<FCI;< in vivo F9G95F7< H<5H G<K5;5B8<5
FCCH 9LHF57H =B &5B96)5F5EI5H &)* =B8I798 )5F?=BGCB=5B ACIG9
AC89@ G<CK98 B9IFC5A9@=CF5H=J9 9::97H 6M =ADFCJ=B; ACHCF ACJ9
A9BHG 5B8 ;F=DD=B; 56=@=HM IFH<9F G<CK98 897@=B9 =B 75H5@5G9 @9J9@G
5B8 F=G9 =B B=HF=H9 5B8 @=D=8 D9FCL=85H=CB @9J9@G H<IG 7CIBH9F65@5B7=B;
DFCCL=85BHG 5B8 CL=85H=J9 GHF9GG =B )5F?=BGCBG 8=G95G9 )F5?5G< 9H 5@
 "B  5 GHI8M G<CK98 5@@9J=5H=CB C: )5F?=BGCBG 6M 9H<5BC@=7
FCCH 9LHF57H C: G<K5;5B8<5 A5>CF@M 6M =B<=6=H=CB C: 5DCDHCH=7 D5H<
K5M 5B8 CL=85H=J9 GHF9GG =B 8CD5A=B9F;=7 B9IFCBG ,=;B=:=75BH =ADFCJ9
A9BH =B CL=85H=J9 GHF9GG 5B8 5DCDHCH=7 GH5H9 =G 8I9 HC H<9 F98I798 9LDF9G
G=CB C: ='(, 5B8 5L 5B8 =B8I7=B; 7@ DFCH9=B 9LDF9GG=CB =B &)* =B
8I798 )5F?=BGCB=5B ACIG9 AC89@ )F5?5G< 9H 5@  !9B79 H<9G9
85H5 GI;;9GHG H<9 B9IFCAC8I@5HCFM 9::97H C: G<K5;5B8<5 0<9F95G :IF
H<9F GHI8=9G 5F9 B99898 HC 5GG9GG H<9 DF97=G9 A97<5B=GA HC GIDDCFH H<9
7@=B=75@ IG9 C: H<9 D@5BH 5G 5B 5BH=D5F?=BGCB=5B 8FI;
4.4. Ashwagandha in schizophrenia
,7<=NCD<F9B=5 =G 89QB98 5G 5 7<FCB=7 DGM7<=5HF=7 8=G95G9 5GGC7=5H98
K=H< D9FHIF65H=CBG =B H<=B?=B; D9F79DH=CB 69<5J=CIF 5B8 CH<9F 7C;B=
H=CB 7<5F57H9F=GH=7G "H 5@GC 5::97HG @5B;I5;9 5B8 75IG9G <5@@I7=B5H=CBG
89@IG=CB 5B8 CH<9F DGM7<CH=7 =@@B9GG 09= 9H 5@  /5F=9HM C: DF9
7@=B=75@ 5B8 7@=B=75@ GHI8=9G 7CB7@I898 H<9 FC@9 C: G<K5;5B8<5 =B HF95H
=B; G7<=NCD<F9B=5 '9IFC@9DH=7G 5F9 K=89@M IG98 =B H<9 H<9F5DM C: G7<=NC
D<F9B=5 "B <5@CD9F=8C@ =B8I798 CFC:57=5@ 8MG?=B9G=5 G<K5;5B8<5 FCCH
9LHF57H 5H 8CG9 C:  A;?; 8CG9 89D9B89BH@M 5A9@=CF5H9G J57I
CIG 7<9K=B; ACJ9A9BHG 5B8 HCB;I9 DFCHFIG=CBG GID9F=CF@M 6M F98I7H=CB
=B @=D=8 D9FCL=85H=CB 5B8 =B7F95G9 =B :CF96F5=B ,( 5B8 75H5@5G9 @9J9@G
K=H< BC 9::97H CB ;@IH5H<=CB9 @9J9@G -<IG G<K5;5B8<5 A5M 69 9:Q
7=9BH =B GIDDF9GG=B; 9LHF5DMF5A=85@ B9IFC@9DH=7=B8I798 9::97HG '5=8I
9H 5@ 
F5B8CA=N98 8CI6@96@=B8 D@5796C7CBHFC@@98 GHI8M <=;<@=;<H98
H<9 FC@9 C: GH5B85F8=N98 9LHF57H C: G<K5;5B8<5 5G 58>IB7H HC HF95H
,7<=NCD<F9B=5 GMADHCAG -<9 9LHF57H 9L<=6=H=B; 5BH==BR5AA5HCFM 5B8
=AAIBCAC8I@5H=CB DFCD9FH=9G F9GI@H =B =ADFCJ=B; DGM7<CD5H<C@C;M 5B8
GHF9GG GMADHCAG =B G7<=NCD<F9B=5 D5H=9BHG <9B;5DD5 9H 5@ 
"B  $IA5F 5B8 7C@@95;I9G 7CB8I7H98 in silico GHI8=9G HC 9LD@CF9 DC
H9BH=5@ C: J5F=CIG D<MHC7<9A=75@G C: G<K5;5B8<5 5G B9IFCDFCH97H=J9
6M =B<=6=H=B; @I'7CBH5=B=B; '& F979DHCF IFH<9F =H DFCJ98 H<5H
@I'7CBH5=B=B; '& <5GH9BG B9IFC89;9B9F5H=CB =B G7<=NCD<F9B=5
-<IG D<MHC7<9A=75@G =B G<K5;5B8<5 5F9 :CIB8 HC 69 DCH9BH=5@ 5BH5;
CB=GH :CF '& F979DHCF 5B8 A5M 69 IG98 :CF HF95HA9BH C: J5F=CIG B9I
FC89;9B9F5H=J9 7CB8=H=CBG $IA5F 5B8 )5HB5=? 
4.5. Ashwagandha in Huntington's disease
!IBH=B;HCBG 8=G95G9 =G 5 DFC;F9GG=J9 B9IFC89;9B9F5H=J9 8=GCF89F
7<5F57H9F=N98 6M 89GHFI7H=CB C: 65G5@ ;5B;@=5 B9IFCBG 5B8 CL=85H=J9
GHF9GG "H =G 5B 5IHCGCA5@ 8CA=B5BH =B<9F=H98 GMB8FCA9 5GGC7=5H98 K=H<
8=GHIF65B79 =B AIG7@9 :IB7H=CB 9ACH=CB5@ 8=GHIF65B79 5B8 89A9BH=5
"H 5@GC =B7@I89G @57? C: :C7IG 7CB79BHF5H=CB 89DF9GG=CB G<CFHH9FA
A9ACFM @CGG @5B;I5;9 GD997< 5B8 ACJ9A9BH DFC6@9AG &5BC<5F5B
9H 5@  &I@H=D@9 @=B9G C: in vivo 5B8 7@=B=75@ 9J=89B79G =AD@=
75H98 G<K5;5B8<5 =B HF95HA9BH C: !IBH=B;HCBG 8=GCF89F '=HFCDFC
D=CB=7 57=8 =B8I7H=CB A=A=7G H<9 56BCFA5@=H=9G G=A=@5F HC !IBH=B;
HCBG 8=GCF89F D5FH=7I@5F@M CL=85H=J9 GHF9GG ;5=H 56BCFA5@=H=9G 5B8 A=
HC7<CB8F=5@ 8MG:IB7H=CB "B<=6=H=CB C: 7CAD@9L "" :IFH<9F 75IG9G 69<5J
=CIF5@ 9BNMA5H=7 5B8 6=C7<9A=75@ 5@H9F5H=CBG G<K5;5B8<5 FCCH 9L
HF57H 5H 8CG9 C:  5B8  A;?; 8CG9 89D9B89BH@M =ADFCJ98 J5F
=CIG 5@H9F5H=CBG 5B8 G<CKG B9IFCDFCH97H=J9 DCH9BH=5@ 8CA=B5BH@M 6M
5BH=CL=85BH 57H=J=HM $IA5F 5B8 $IA5F 

UNCORRECTED PROOF
S. Zahiruddin et al. Journal of Ethnopharmacology xxx (xxxx) xxx-xxx
IFH<9F H<9 =BJC@J9A9BH C: 9F;=7 GMGH9A =B !IBH=B;HCBG 8=G95G9
D5H<C;9BG=G <5G 699B F9DCFH98 G<K5;5B8<5 57HG 6M 9F;=7 GMGH9A
5B8 5BH=CL=85BH DCH9BH=5@ F9GHCF9G 579HM@ 7<C@=B9GH9F5G9 5B8 ;@IH5H<=CB9
9BNMA9 @9J9@ 5B8 =ADFCJ9G 7C;B=H=J9 :IB7H=CB H<IG A5?=B; =H GI=H56@9
75B8=85H9 :CF H<9 HF95HA9BH C: !IBH=B;HCBG 8=GCF89F $IA5F 5B8 $I
A5F 
4.6. Ashwagandha in dyslexia
MG@9L=5 =G H<9 6F5=B 5GGC7=5H98 8=GCF89F DF=A5F=@M 7<5F57H9F=N98 6M
@95FB=B; 8=G56=@=HM 8=:Q7I@HM =B F958=B; 5B8 GD9@@=B; KCF8G 577IF5H9@M
5B8 RI9BH@M /5F=CIG CH<9F GMADHCAG GI7< 5G =AD5=FA9BH =B A9ACFM
GD997< J=GI5@ 5B8 ACHCF 7CBHFC@ 5F9 5@GC 5GGC7=5H98 K=H< 8MG@9L=5 I@@
 )<CBC@C;=75@ 7C8=B; 89:97HG =9 :5=@IF9 HC GD95? 5B8 ;9H H<9
GCIB8 C: 5 KCF8 @57?=B; D<CB9A=7 8=J=G=CB =9 DCK9F@9GGB9GG HC 6F95?
5 KCF8 =BHC D5FH GCIB8G DCCF JC756I@5FM 58J5B79A9BH 5B8 =B7CBJ9
B=9B79 =B G9;F9;5H=B; @=B;I=GH=7 5B8 GMBH57H=7 7CBHF5GHG 5ACB; KCF8G 5B8
GCIB8G 5F9 7CAACB ?9M GMADHCAG C: 8MG@9L=5 %MCB 9H 5@  =:
:9F9BH 7@=B=75@ 5B8 9LD@CF5HCFM F9G95F7< =B F9:9F9B79 HC G<K5;5B8<5 8=
F97H@M CF =B8=F97H@M ;5J9 7CBQFA5H=CBG =B F9;5F8 HC DFC;F9GG =B 7C;B=H=J9
:IB7H=CBG K<=7< A=;<H 69 IG9:I@ =B =ADFCJ=B; H<9 =B56=@=HM =B 8MG@9L=5
,<5FA5 9H 5@  "B  <I@9M F9DCFH98 =ADFCJ9A9BH =B A9A
CFM7CBGC@=85H98 =B8I798 6M 9@97HFC7CBJI@G=J9 G<C7? =B A=79 F979=J=B;
G<K5;5B8<5 FCCH 9LHF57H <I@9M 
4.7. Ashwagandha in depression
9DF9GG=CB =G 5 <9H9FC;9B9CIG 8=GCF89F 5GGC7=5H98 K=H< 6F5=B <95@H<
A5=B@M ACC8 GK=B;G 5B8 H<CI;<HG A=G69<5J=CIF 8=G5DDC=BHA9BHG G58
B9GG <CD9@9GGB9GG 5B8 @CGG C: D<MG=75@ 57H=J=H=9G 5B8 G9@:KCFH< "B 588=
H=CB 89DF9GG=CB =G 577CAD5B=98 K=H< 8=GHIF65B79 =B 5DD9H=H9 G@99D D5H
H9FB 5B8 CH<9F 85=@M KCF? 5@CB; K=H< GMADHCAG C: 5BL=9HM <A98 9H
5@  LD9F=A9BH5@ GHI8=9G <5J9 F9DCFH98 H<9 5A9@=CF5H=J9 9::97H
C: G<K5;5B8<5 =B 89DF9GG=CB
"B  <5HH57<5FM5 9H 5@ =GC@5H98 H<9 6=C57H=J9 7CADCIB8 ;@M
7CK=H<5BC@=89G :FCA G<K5;5B8<5 FCCHG 5B8 =BJ9GH=;5H98 =HG DCH9BH=5@
5G 5BH=89DF9GG5BH 5H H<9 8CG9 C:  5B8  A;?; @M7CK=H<5BC@=89G
K9F9 :CIB8 HC 9L<=6=H 7CAD5F56@9 5BH=89DF9GG5BH 9::97H HC =A=DF5A=B9
=B 69<5J=CIF5@ 89GD5=F 5B8 @95FB98 <9@D@9GGB9GG =B8I798 6M :CF798 GK=A
H9GHG -<9F96M GIDDCFH=B; H<9 IG9 C: G<K5;5B8<5 5G ACC8 GH56=@=N9F
<5HH57<5FM5 9H 5@ 
+9DCFHG CB MIFJ98=7 :CFAI@5H=CBG 7CBH5=B=B; G<K5;5B8<5 G<
K5;5B8<5 ;<FIH<5 :5H 9LHF57H GIDDCFH98 =HG DCH9BH=5@ 5G 5BH=89DF9G
G5BH 6M G=;B=:=75BH@M F98I7=B; =AAC6=@=HM H=A9 =B :CF798 GK=A H9GH =B
8I798 69<5J=CIF5@ 89GD5=F H5=@ GIGD9BG=CB H9GH 5B8 F9G9FD=B9 5BH5;C
B=GA =B 5BH=F9G9FD=B9 H9GH 5H 5 8CG9 C:  A;?; #5M5BH<=  B
CH<9F GHI8M 9J5@I5H98 H<9 FC@9 C: G<K5;5B8<5 =B 89DF9GG=CB H<FCI;<
@95FB98 <9@D@9GGB9GG 5B8 :CF798 GK=AA=B; H9GH "H =G 5@GC F9DCFH98 9B
<5B798 5BH=89DF9GG5BH 9:Q757M 6M 7CA6=B=B; G<K5;5B8<5 K=H<
=A=DF5A=B9 =B 5B=A5@ AC89@ &5=HM 9H 5@ 
4.8. Ashwagandha in autism
IH=GA =G H<9 6F5=B =BR5AA5HCFM 8=GCF89F 5GGC7=5H98 K=H< 8=G56=@=
H=9G C: @95FB=B; 5B8 GC7=5@ 57H=J=HM "H =G 7<5F57H9F=N98 6M CL=85H=J9 GHF9GG
5GHFC7MH9G 5B8 A=7FC;@=5 57H=J5H=CB 5@H9F5H=CB =B DFC=BR5AA5HCFM 7M
HC?=B9G CLC;I5BCG=B9 5B8 B9IFCB5@ 89DF9GG=CB "H 5@GC =B7@I89G <=;<
:CC8 =BHC@9F5B79 5BL=9HM =B7F95G=B; 5IHC5BH=6C8=9G C: 5BH=6F5=B DFC
H9=B @CK9F=B; @9J9@G C: F98I798 ;@IH5H<=CB9 GI@:5H=CB 5B8 A9H<M@5
H=CB +5GCC@ 9H 5@  +979BH F9DCFH =B8=75H98 H<9 DCH9BH=5@ C:
G<K5;5B8<5 =B GC8=IA J5@DFC5H9 =B8I79 5IH=GA =B FC89BH AC89@ 6M
=ADFCJ9A9BH =B 5@H9F98 69<5J=CIF5@ 5B8 CL=85H=J9 GHF9GG +9GHCF5H=CB
=B BIA69F C: DIF?=B>9 Q6F9G B9IFCB5@
89;9B9F5H=CB 5B8 7<FCA5HC@MG=G =B <=GHC5F7<=H97HIF9 GHI8=9G C: 79F969@
@IA :IFH<9F 7CBQFAG =HG 5A9@=CF5H=J9 9::97H =B 5IH=GA /99F9G< 9H 5@

4.9. Ashwagandha in addiction
88=7H=CB =G 89QB98 5G 7CAD@9L 7<FCB=7 6F5=B 8=GCF89F 5GGC7=5H98
K=H< D<MG=75@ 5B8 DGM7<C@C;=75@ 89D9B89B79 CB 7<9A=75@ 8FI; CF 57H=J
=HM "H =G 7<5F57H9F=N98 6M 5@H9F5H=CBG =B 69<5J=CIF H<=B?=B; 6C8M :IB7
H=CBG @95FB=B; A9ACFM 5B8 897=G=CB A5?=B; J9F=HH 5B8 +C66=BG
 "H A5=B@M =B7@I89G IG9 C: 5@7C<C@ 7C75=B9 B=7CH=B9 A5F=>I5B5
CD=C=8 75::9=B9 =B<5@5BHG CF 57H=J=HM @=?9 ;5A6@=B; -F5BG8I7H=CB 5B8
HF5BG7F=DH=CB :57HCFG 5F9 :CIB8 HC 69 5GGC7=5H98 =B 89J9@CD=B; 5B8 A5=B
H5=B=B; 588=7H=CB =B AC@97I@5F GHI8=9G $CC6 5B8 /C@?CK 
"B 5 F979BH GHI8M =H =G F9DCFH98 H<5H G<K5;5B8<5 =B<=6=HG H<9 GH=A
I@5H=CB C: B9IFCB 7=F7I@5H=CB 5B8 8CD5A=B9 HF5BGA=GG=CB GD97=:=75@@M =B
J9BHF5@ H9;A9BH5@ F9;=CB C: 8CD5A=B9F;=7 B9IFCBG 5B8 =B H<9 BI7@9IG 57
7IA69BG G<9@@ H<IG DF9J9BH=B; H<9 5@H9F5H=CB C: 69<5J=CIF 5B8 6=C7<9A
=75@ 7<5B;9G 75IG98 8I9 HC 9@97HFC7<9A=75@ 5B8 B9IFC7<9A=75@ AC8=Q
75H=CBG =B8I798 6M ACFD<=B9 5B8 9H<5BC@ 5GG5F9C 9H 5@ 
BCH<9F GHI8M =BJ9GH=;5H98 H<9 5A9@=CF5H=J9 9::97H C: G<K5;5B8<5
9LHF57H =B DF9J9BH=B; B=7CH=B9 5HHF=6IH98 588=7H=CB "H K5G 7CB7@I898
H<5H G<K5;5B8<5 5HH9BI5H9G B=7CH=B9 =B8I798 D@579 DF9:9F9B79 7CB8=
H=CB A=79 H<IG <=;<@=;<H=B; 5BH=588=7H=J9 DCH9BH=5@ 8I9 HC AC8I@5H=CB
C: B=7CH=B9 7<C@=B9F;=7 F979DHCF IACF9 9H 5@ 
+979BH@M 5 D5H9BH <5G 5@GC 699B Q@98 5B8 DI6@=G<98 K=H< DI6@=75
H=CB BIA69F .,   K<=7< 9B@=GH98 J5F=CIG A98=7=B5@
D@5BHG =AD5FH=B; 5BH=GAC?=B; DCH9BH=5@ K=H< G<K5;5B8<5 5G CB9 C:
H<9A IFH<9FACF9 H<9 GMB9F;=GH=7 DCH9BH=5@ C: G<K5;5B8<5 K=H< J5F
=CIG CH<9F D@5BHG =B :CFAI@5H=B; B=7CH=B9 :F99 5BH=GAC?=B; :CFAI@5H=CB
<5G 5@GC 699B F9DCFH98 -5AC@= 
BCH<9F GHI8M F9DCFH98 H<5H =B 7<FCB=7 5@7C<C@ 9LDCGIF9 G<K5
;5B8<5 7<IFB5 75IG9G F98I7H=CB =B 6CH< K=H<8F5K5@ 5BL=9HM 5B8 =BH5?9
C: 9H<5BC@ CA=B5BH@M H<9 A97<5B=GA =BJC@J98 =B 5BH=588=7H=CB =G J=5
AC8I@5H=CB C: 9F;=7 5B8 G9FCHCB9F;=7 GMGH9A 5BG5@ 5B8 5B9F
>99  "B J=9K C: G9J9F5@ 56CJ9 GHI8=9G G<K5;5B8<5 =G :CIB8 HC
69 9::97H=J9 =B F9J9FG=B; 588=7H=CB
4.10. Ashwagandha in amyotrophic lateral sclerosis
AMCHFCD<=7 @5H9F5@ G7@9FCG=G 5@GC ?BCKB 5G :FCBHCH9ADCF5@ @C65F 89
;9B9F5H=CB =G AI@H=:57HCF=5@ B9IFC89;9B9F5H=J9 8=GCF89F 5::97H=B; B9I
FCBG =BJC@J98 =B ACHCF 57H=J=H=9G 5B8 JC@IBH5FM AIG7@9G "H 65G=75@@M =B
7@I89G 5@H9F5H=CB C: IDD9F 5B8 @CK9F ACHCF B9IFCBG =B 79F96F5@ 7CFH9L
5B8 @5HH9F =B A98I@@5 5B8 5BH9F=CF <CFB C: GD=B5@ 7CF8 5=@IF9 =B IDD9F
ACHCF B9IFCBG F9GI@H =B AIG7@9 GH=TB9GG 5B8 GD5GH=7=HM K<9F95G @CK9F
ACHCF B9IFCBG @958 HC AIG7@9 HK=H7<=B; :IFH<9F @958=B; HC 89;9B9F5H=CB
5B8 @CGG =B 7CBB97H=J=HM =B GMB5DG9 H<IG F9GI@H=B; 5HFCD<M FCKB 5B8
@<5@56=  "H =G :CIB8 HC =B=H=5H9 H<9 :C75@ K95?B9GG K<=7< :IF
H<9F 9G75@5H9G HC AIG7@9G 85A5;9 =B7@I8=B; F9GD=F5HCFM AIG7@9G G<K5
;5B8<5 =B ,(  A=79 K5G :CIB8 HC G@CK 8CKB H<9 8=G95G9 DFC;F9G
G=CB =ADFCJ98 ACHCF D9F:CFA5B79 5B8 =B7F95G98 H<9 BIA69F C: ACHCF
B9IFCBG =B @IA65F GD=B5@ 7CF8 8I9 HC =B8I7H=CB C: 5IHCD<5;M 57H=J=HM
88=H=CB5@@M H<9 @9J9@G C: A=G:C@898 ,( K9F9 8=A=B=G<98 5B8 D<CG
D<CFM@5H=CB C: 'κ K5G DF9J9BH98 IHH5 9H 5@ 
4.11. Ashwagandha in attention de<cit hyperactivity disorder
HH9BH=CB 89Q7=H <MD9F57H=J=HM 8=GCF89F ! =G 5 <9H9FC;9B9CIG
6F5=B 8=GCF89F 5GGC7=5H98 K=H< 8=GHF57H=6=@=HM CF =B5HH9BH=CB

UNCORRECTED PROOF
S. Zahiruddin et al. Journal of Ethnopharmacology xxx (xxxx) xxx-xxx
A5M CF A5M BCH 577CAD5BM K=H< <MD9F57H=J=HM "H =G ACF9 7CAACB =B
7<=@8F9B 5B8 C:H9B G99AG HC 69;=B =B 7<=@8<CC8 5B8 A5M 7CBH=BI9 :IF
H<9F HC 58I@H<CC8 A5L=A5@@M C77IFG =B A5@9G H<5B =B :9A5@9G "H A5=B@M
=BH9F:9F9G K=H< :IB7H=CB=B; 5B8 89J9@CDA9BH 6M 5@H9F5H=CB 5B8 =BH9FFID
H=CB C: :C7IG H5G?G H<=B?=B; 89G=F9 ;F5H=Q75H=CB H5@?G 5HH9BH=CB 897=
G=CB 69<5J=CIF 9H7 5F?@9M  "H 7CC77IFG K=H< BIA69F C: 6F5=B
8=GCF89FG =B7@I8=B; ACC8 5BL=9HM 5B8 7CB8I7H 8=GCF89FG =989FA5B
9H 5@  "H =G 7<5F57H9F=N98 6M 5@H9F5H=CB =B 8CD5A=B9 5B8 BCF9D=
B9D<F=B9 F9IDH5?9 H<IG A98=75H=CBG K<=7< 6@C7?G 8CD5A=B9F;=7 5B8 BC
F58F9B9F;=7 57H=J=HM =B<=6=HG ! =989FA5B 
'CCHFCD=7 9::97HG C: J5F=CIG <9F6G =B7@I8=B; G<K5;5B8<5 D@5MG 5B
=ADCFH5BH FC@9 =B HF95H=B; 5B8 DF9J9BH=B; ! &I@H=D@9 7@=B=75@ HF=
5@G 5B8 5B=A5@ GHI8=9G <5J9 F9DCFH98 =HG IG9 =B 5BL=9HM 7C;B=H=J9 5B8
B9IFC@C;=75@ 8=GCF89FG <5HH57<5FM5 9H 5@  $5BM5=M55 5B8
7C@@95;I9G F9DCFH98 =AAIBCAC8I@5HCFM 5B8 ', 9::97HG C: B9K ;@M
7CK=H<5BC@=89G A5=B@M G=HC=B8CG=89 "1 5B8 G=HC=B8CG=89 1 5H 8CG9 C:
 A;?; $5BM5=M55 9H 5@  -<IG G<K5;5B8<5 K5G
:CIB8 HC 69 69B9Q7=5@ =B ! 8I9 HC =HG =AAIBCAC8I@5HCFM 5B8 ',
9::97HG A5=B@M =B GHF9GG A9ACFM 5B8 @95FB=B; !CK9J9F :IFH<9F GHI8=9G
=B7@I8=B; 6CH< 5B=A5@ 5B8 7@=B=75@ HF=5@G 5F9 F9EI=F98 HC F9J95@ H<9 A97<
5B=GH=7 D5H<K5M C: G<K5;5B8<5 =B !
4.12. Ashwagandha in bipolar disorder
=DC@5F 8=GCF89F 5@GC ?BCKB 5G A5B=7 89DF9GG=CB =G 5 6F5=B 8=GCF89F
H<5H 9::97HG A9BH5@ <95@H< 6M 75IG=B; 9LHF9A9 GK=B;G =B ACC8 A5=B@M
89DF9GG=CB 5B8 A5B=5 CF <MDCA5B=5 9@A5?9F  "H =G 5GGC7=5H98
K=H< G58B9GG <CD9@9GGB9GG @CK =BH9F9GH @57? C: D@95GIF9 G@99D@9GGB9GG
<=;< 9B9F;M >I8;9A9BH5@ 69<5J=CIF 5@H9F5H=CB 9ID<CF=7 <=;< 9B9F;M
=FF=H56=@=HM K<=7< =G 9=H<9F 9ACH=CB5@ <=;<G =9 A5B=5 CF <MDCA5B=5 CF
@CKG =9 89DF9GG=CB !5@@I7=B5H=CB 5BL=9HM =BGCAB=5 ! DCGHHF5I
A5H=7 GHF9GG 5B8 CH<9F GMADHCAG A5M 7CC77IF K=H< 6=DC@5F 8=GCF89F
F5B89 9H 5@  -=@@ 85H9 CB9 GHI8M <5G 699B 7CB8I7H98 HC F9
DCFH H<9 FC@9 C: G<K5;5B8<5 =B 6=DC@5F 8=GCF89F C;B=H=J9 8MG:IB7H=CB
@958G HC 5@H9F5H=CB =B :IB7H=CB5@ F97CJ9FM =B 6=DC@5F 8=GCF89F +5B8CA
=N98 D@5796C7CBHFC@@98 GHI8M F9DCFH98 H<9 9:Q757M C: G<K5;5B8<5 5H
8CG9 C:  A;85M 5G 58>IB7H =B 6=DC@5F 8=GCF89F G<K5;5B8<5 K5G
:CIB8 HC 69 G=;B=:=75BH@M 69B9Q7=5@ 5G 7CAD5F98 HC D@5796C =B 7C;B=H=J9
H5G?G <9B;5DD5 9H 5@ 
)FC656@9 A97<5B=GA =BJC@J98 =B 56CJ9 A9BH=CB98 J5F=CIG 6F5=B 8=G
CF89FG 6M F9DCFH98 57H=J9 7CBGH=HI9BHG C: G<K5;5B8<5 =G GIAA5F=N98 =B
=;
5. Safety assessment studies of Ashwagandha
'IA9FCIG GHI8=9G <5J9 699B 7CB8I7H98 6M J5F=CIG F9G95F7<9FG HC
9J5@I5H9 H<9 HCL=7 9::97HG C: G<K5;5B8<5 "H =G 7CBG=89F98 5G <95@H<M
G5:9 5B8 89D9B856@9 8FI; ,I657IH9 HCL=7=HM GHI8=9G K5G 7CB8I7H98 6M
D<5@9 5B8 7C@@95;I9G CB 7CA6=B5H=CB C: G<K5;5B8<5 5B8 =BG9B;
:CF  85MG =B H<F99 8CG9G 5B8 :CIB8 HC =B7F95G9 6C8M K9=;<H 5B8 @=J9F
K9=;<H 6IH =ADFCJ9A9BH =B <9A5HC@C;=75@ D5F5A9H9FG K5G C6G9FJ98
!=GHCD5H<C@C;=75@ 5B8 ;FCGG 9J5@I5H=CB C: 6F5=B ?=8B9M <95FH @=J9F
GD@99B ?=8B9M H9GH=G 5B8 CJ5F=9G K5G :CIB8 HC 69 BCFA5@ -<IG H<9
GHI8M F9J95@98 BC HCL=7 9::97HG =B F5HG D<5@9 9H 5@ 
"B 5BCH<9F GHI8M 5@7C<C@=7 9LHF57H C: G<K5;5B8<5 FCCH K5G
G7F99B98 :CF =HG 57IH9 HCL=7=HM =B ,K=GG 5@6=BC A=79 5B8 GI657IH9 HCL
=7=HM =B 0=GH5F F5HG 5H 5 8CG9 C:  A;?; 58A=B=GH9F98 =BHF5D9F=
HCB95@@M 'C ACFH5@=HM K5G :CIB8 5H H<9 H<9F5D9IH=7 8CG9 <CK9J9F =B
7F9A9BH C: 8CG9 HC  A;?; @98 HC 895H< -<IG % K5G :CIB8 HC
69  A;?; 6C8M K9=;<H "B GI657IH9 HCL=7=HM  A;?; 8CG9 C:
9LHF57H K5G 58A=B=GH9F98 :CF  85MG 5B8 BC 7<5B;9G K9F9 F9DCFH98
=B 6@CC8 D5F5A9H9FG !CK9J9F 5 897F95G9 =B GD@99B H<MAIG
5B8 58F9B5@ K9=;<HG =B A5@9 F5HG 5B8 5B =B7F95G9 =B 57=8 D<CGD<5H5G9
7CBH9BH K5G C6G9FJ98 6IH CH<9F 6=C7<9A=75@ D5F5A9H9FG K9F9 :CIB8 HC
69 =B BCFA5@ F5B;9G =B 6CH< G9L9G ,<5F585 9H 5@ 
"B  5 GHI8M K5G 7CB8I7H98 HC 9J5@I5H9 H<9 HCL=7 9::97HG C: <M
8FC5@7C<C@=7 FCCH 9LHF57H C: G<K5;5B8<5 +CCH 9LHF57H K5G 58A=B=G
H9F98 HC F5HG 5H 8CG9 C:  A;?; CF5@@M CB79 5B8 C6G9FJ98 :CF 
85MG 'C HCL=7 9::97HG 5B8 ACFH5@=HM K5G F9DCFH98 =B 57IH9 HCL=7=HM GHI8M
IFH<9F =B GI657IH9 HCL=7=HM GHI8M F5HG K9F9 58A=B=GH9F98 H<9 9LHF57H 5H
8CG9 C:   5B8  A;?; :H9F  85MG BC 7<5B;9G K9F9 C6
G9FJ98 =B 6C8M 5B8 J5F=CIG CF;5BG K9=;<H 'C 8CG9 F9@5H98 7<5B;9G K9F9
:CIB8 =B <59A5HC@C;=75@ 5B8 6=C7<9A=75@ D5F5A9H9FG 5B8 BC HF95HA9BH
F9@5H98 <=GHCD5H<C@C;=75@ @9G=CBG K9F9 BCH98 -<IG H<9 GHI8M 7@5=A98 BC
HCL=7 9::97HG C: <M8FC5@7C<C@=7 FCCH 9LHF57H C: G<K5;5B8<5 5H 8CG9 @9J9@
C:  A;?; 6C8M K9=;<H D9F 85M =B F5HG )F56I 9H 5@ 
+979BH@M 5 GHI8M K5G 7CB8I7H98 HC 9J5@I5H9 H<9 7<FCB=7 HCL=7 9::97HG
C: G<K5;5B8<5F=G<H5 CB ?=8B9M :IB7H=CBG -<9 GHI8M =B7@I898 58A=B=G
HF5H=CB C: G<K5;5B8<5F=G<H5 HC 6CH< A5@9 5B8 :9A5@9 5@6=BC F5HG :CF 
85MG 5B8 C6G9FJ98 7<5B;9 =B G9FIA IF95 IF=7 57=8 5B8 7F95H=B=B9 @9J9@G
"B A5@9 F5HG G9FIA @9J9@G C: IF95 5B8 IF=7 57=8 8=8 BCH G<CK 5BM G=;
B=:=75BH 7<5B;9 5H 5@@ H<F99 8CG9G =9 @CK A98=IA 5B8 <=;< 8CG9 6IH
G9FIA 7F95H=B=B9 @9J9@G K9F9 :CIB8 HC 69 =B7F95G98 =B A98=IA 8CG9 @9J9@
;FCID !CK9J9F =B :9A5@9 F5HG BC G=;B=:=75BH 7<5B;9G K9F9 C6G9FJ98 =B
@9J9@G C: G9FIA IF95 IF=7 57=8 5B8 7F95H=B=B9 =B F9GD97H HC @CK A98=IA
5B8 <=;< 8CG9 @9J9@G +5<A5B 9H 5@ 
BCH<9F F979BH GHI8M K5G 7CB8I7H98 6M $IA5F 9H 5@ <=;<@=;<HG H<9
57IH9 5B8 GI657IH9 HCL=7=HM GHI8=9G CB D5H9BH98 DC@M <9F65@ :CFAI@5
H=CB K<=7< 7CBH5=BG FCCHG C: G<K5;5B8<5 5G CB9 C: H<9 =B;F98=9BH
'C ACFH5@=HM K5G C6G9FJ98 =B 57IH9 HCL=7=HM GHI8M "B GI657IH9 HCL=7
=HM GHI8=9G 85=@M :CC8 =BH5?9 K5H9F =BH5?9 6=C7<9A=75@ <9A5HC@C;=75@
5B8 <=GHCD5H<C@C;=75@ D5F5A9H9F :5=@98 HC 9L<=6=H 5BM G=;B=:=75BH 7<5B;9
@GC BC A5>CF 7<5B;9G =B 6=C7<9A=75@ 9BNMA9G =B7@I8=B; @=J9F 5B8 F9B5@
9BNMA9G A5=B@M , (- , )- %) %! - 5B8 ) K9F9 C6G9FJ98
$IA5F 9H 5@  -<IG :FCA H<9 56CJ9 GHI8=9G G<K5;5B8<5 =G
:CIB8 HC 69 G5:9 5B8 A5M :IFH<9F 69 9LD@CF98 :CF H<9F5D9IH=7 IH=@=N5
H=CB G BC HCL=7=HM K5G C6G9FJ98 =B 57IH9 GI657IH9 5B8 7<FCB=7 HCL=7
=HM GHI8=9G K<=7< 89H9FA=B9G H<9 K=89 G5:9HM A5F;=B C: G<K5;5B8<5
6. Recent patents of Ashwagandha in brain disorders
IFF9BH@M D5H9BHG 5F9 7CBG=89F98 5G H<9 ACGH G=;B=:=75BH 5B8 F9@=
56@9 GCIF79 C: =B:CFA5H=CB )5H9BHG 7CBH5=B =B:CFA5H=CB =B 5@@ 89DH<G 5B8
6F95H<G 5B8 =G 9GH=A5H98 H<5H  =B:CFA5H=CB 5F9 BCH 5J5=@56@9 5BM
K<9F9 9@G9
/5F=CIG D5H9BHG CB G<K5;5B8<5 5F9 5J5=@56@9 9=H<9F 5@CB9 CF =B
7CA6=B5H=CBG K=H< CH<9F A98=7=B5@ D@5BHG :CF IG9 =B J5F=CIG 8=G95G9G =B
7@I89G 5BH=A=7FC6=5@ 5BH=@=D=89A=7 5BH=8=569H=7 5BH=DMF9H=7 5BH==B
R5AA5HCFM 5BH=5;9=B; 5BH=!"/ 5BH=5FH<F=H=7 5BH=657H9F=5 5BH=A=
7FC6=5@ 5BH=<MD9F@=D=89A=7 5BH=75B79F 6F5=B 8=GCF89FG 9H7 +979BH
D5H9BHG =B D9F=C8 :FCA  HC  <5J9 699B 9B@=GH98 =B -56@9
7. Discussion & conclusion
+9J=9K =G 5B =ADCFH5BH HCC@ HC GIAA5F=N9 H<9 9J=89B79G F9@5H=B;
HC 9::97H=J9B9GG C: <95@H< 75F9 =BH9FJ9BH=CBG 577IF5H9@M 5B8 F9@=56@M
"B H<=G F9J=9K K9 9J5@I5H98 H<9 9::97HG C: G<K5;5B8<5 CB 6F5=B F9
@5H98 8=GCF89FG G<K5;5B8<5 5B8 =HG 9LHF57H <5J9 699B IG98 G=B79
897589G HC HF95H J5F=CIG 8=CF89FG G<K5;5B8<5 =G @5F;9@M IG98 5G 5B
=AAIBCAC8I@5HCF =B F979BH H=A9G 5B8 =B8=75H98 5BH=8=569H=7 <9D5HC
DFCH97H=J9 5BH=75B79F 5BH==BR5AA5HCFM 57H=J=HM 5G K9@@ G<K5;5B8<5
<5G ;5=B98 =BH9F9GH :FCA H<9 @5GH H<F99 897589 :CF =HG DCH9BH=5@ =B 6F5=B
F9@5H98 8=GCF89FG G<K5;5B8<5 =G 7<9A=75@@M 9BF=7<98 K=H< BIA9F
CIG 57H=J9 7CBGH=HI9BHG GI7< 5G K=H<5BC@=89G

UNCORRECTED PROOF
S. Zahiruddin et al. Journal of Ethnopharmacology xxx (xxxx) xxx-xxx
Fig. 3. ,IAA5FM C: DFCDCG98 A97<5B=GA =BJC@J98 =B AI@H=D@9 6F5=B 8=GCF89F 6M 57H=J9 7CBGH=HI9BHG C: G<K5;5B8<5 FCCH
G=HC=B8CG=89G 5B8 G9J9F5@ J5@I56@9 5@?5@C=8G H<5H <5J9 699B 9LD@CF98
H<FCI;< J5@=8 G7=9BH=Q7 5B5@MG=G -<9G9 7CBGH=HI9BHG <5J9 699B 8C7I
A9BH98 HC 69 IG9:I@ :CF 7IF=B; 6F5=B F9@5H98 8=GCF89F ,9J9F5@ GHI8=9G 5F9
69=B; 7CB8I7H98 KCF@8K=89 HC 9LD@CF9 H<9 D<5FA57C@C;=75@ 69B9QHG C:
H<9 D@5BH 5B8 =HG 7CBGH=HI9BHG
"B "B8=5 G<K5;5B8<5 =G IG98 5G 5 <CIG9<C@8 F9A98M 5B8 =G 7CBG=8
9F98 5G H<9 69GH A9ACFM 9B<5B7=B; HCB=7 :CF H<9 9@89F@M 5B8 7<=@8F9B "H
=G CB9 C: H<9 69GH B9FJ=B9 HCB=7G =B MIFJ985 H<9 ACGH 5B7=9BH GMGH9A C:
A98=75@ G7=9B79G ,=B;< 9H 5@  /5F=CIG DI6@=75H=CBG CB G<K5
;5B8<5 <5J9 F9DCFH98 =HG 9::97H=J9B9GG :CF 6F5=B F9@5H98 8=GCF89FG "H <5G
699B D9F79=J98 H<5H ACGH C: H<9 DI6@=G<98 85H5 5F9 65G98 CB in vitro 5B8
in vivo GHI8=9G 5B8 :9K 7@=B=75@ 85H5 =G 5J5=@56@9 HC GIDDCFH =HG 9J=89B79
C: 57H=J=H=9G =B AI@H=D@9 8=G95G9G -<9F9 =G BC 8=F97H GHI8M HC 7CAD5F9 H<9
9::97H C: G<K5;5B8<5 5B8 =HG 9LHF57H K=H< 9GH56@=G<98 5DDFCJ98 8FI;G
=B 5 ;=J9B =B8=75H=CB -<IG G<K5;5B8<5 5B8 =HG 9LHF57H AIGH 69 7CB
G=89F98 5G 5 8=9H5FM GIDD@9A9BH BCH 5G 5 8FI;
-<9 F9DCFH98 G7=9BH=Q7 85H5 GIDDCFHG H<5H G<K5;5B8<5 =G 5 F95@
DCH9BH F9;9B9F5H=J9 HCB=7 8I9 HC =HG AI@H=D@9 D<5FA57C@C;=75@ 57H=CBG
@=?9 5BH=GHF9GG 5B8 B9IFCDFCH97H=J9 "H =G IG9:I@ :CF 8=::9F9BH HMD9G C:
B9IFC89;9B9F5H=J9 8=G95G9G GI7< 5G )5F?=BGCBG !IBH=B;HCBG 5B8
@N<9=A9FG 8=G95G9G
-<9 A97<5B=GA F9GDCBG=6@9 :CF G<K5;5B8<5 5G B9IFCDFCH97H=J9 HC
H<9 @5F;9F 89;F99 =G 8I9 HC =HG 5BH=CL=85BH 57H=J=HM BH=CL=85BH 57
H=J=HM =G 7CBG=89F56@M 8I9 HC 5 897F95G9 CF BCFA5@=N5H=CB =B F9J9FG98
@=D=8 D9FCL=85H=CB @9J9@G <5HH57<5FM5 9H 5@  5B8 =B7F95G9
CF BCFA5@=N5H=CB C: 9@9J5H98 GID9FCL=89 8=GAIH5G9 @9J9@G A5=B@M =B
79F969@@IA GHF=5HIA <=DDC75ADIG :FCBH5@ 7CFH9L 9H7 K<=7< AIGH
69 :C@@CK98 6M 57H=J=HM C: 9BNMA9G 75H5@5G9 )F5?5G< 9H 5@ 
5B8 ;@IH5H<=CB9 D9FCL=8=G9 IDH5 9H 5@  =B GHF=5HIA 7CF
H9L <=DDC75ADIG 5B8 CH<9F D5FHG C: 6F5=B G<K5;5B8<5 5@GC F9;I
@5H9G BCB9BNMA5H=7 5BH=CL=85BH @9J9@G 6M F9GHCF=B; H<9 @9J9@G C: ;@I
H5H<=CB9 K<=7< =G 5B 9B8C;9BCIG A9A69F C: 5BH=CL=85BH 89:9B79 GMG
H9A &5<9F  @IH5H<=CB9 57HG 6M F957H=B; K=H< CLM;9B :F99
F58=75@G CF;5B=7 D9FCL=89G 5B8 5@GC F9;I@5H9 9BNMA9G ;@IH5H<=CB9

UNCORRECTED PROOF
S. Zahiruddin et al. Journal of Ethnopharmacology xxx (xxxx) xxx-xxx
Table 4
%=GH C: D5H9BHG DI6@=G<98 :FCA  HC  CB G<K5;5B8<5 F9@5H98 HC 6F5=B 8=GCF89FG
)5H9BHBC
)I6@=75H=CB
85H9 -=H@9 7H=J=HM
#)  'IHF=9BH7CADCG=H=CB BH=CL=85BH
.,  IB7H=CB5@:CFAI@5H=CB=B7<9K=B;;IA +98I7H=CBC:GHF9GG5B8CF9B<5B79A9BHC:9B9F;M5B8
A9BH5@7@5F=HM
.,  CADCG=H=CBG5B8&9H<C8G:CF"ADFCJ=B;,@99D.G=B;'IHF579IH=75@
CFAI@5H=CB
&5=BH5=BGG@99D5GK9@@5G5@@9J=5H9D5=BHC=ADFCJ9G@99D
.,  'IHF579IH=75@:CFAI@5H=CB:CFHF95HA9BHC:5BL=9HM5B889DF9GG=CB BH=5BL=9HM5B85BH=89DF9GG=CB
.  &I@H=7CADCB9BH:CFAI@5H=CB:CF=ADFCJ=B;B9IFC@C;=75@:IB7H=CB -F95HA9BHC:B9IFC@C;=75@5B8B9IFCDGM7<=5HF=78=G95G9G
  DFC79GGHC9B<5B79H<96=C57H=J=HMC:5G<K5;5B8<59LHF57HG "AAIBCAC8I@5HCFM57H=J=HM5BH==BR5AA5HCFM57H=J=HM
5BH=GHF9GG57H=J=HM5BH=8=569H=757H=J=HM5B8G@99DEI5@=HM
)  "B8C@95@?M@5A=BCK=H<5GH9FC=87CB>I;5H9G5B8A9H<C8C:IG9 BH=@N<9=A9FG5BH5BL=9HM5B85BH=
89DF9GG=J9 8=GCF89FG
0(  CADCG=H=CBG:CFA9BH5@5@9FHB9GG5B8A9H<C8GC:A5?=B;5B8IG=B;H<9F9C: &9BH5@5@9FHB9GG
.,  .G9C:5K=H<5B=59LHF57H:CFH<9HF95HA9BHC:5AM@C=8F9@5H988=G95G9G AM@C=8F9@5H988=G95G9G=B7@I8=B;@N<9=A9F8=G95G9
.,  &I@H=:IB7H=CB5@:CFAI@5H=CB7CADF=G98C:B5HIF5@=B;F98=9BHG5B8A9H<C8C:
DF9D5F5H=CBA5BI:57HIF=B;H<9F9C:
BH=@N<9=A9FG5B8AI@H=D@9G7@9FCG=G
0(  IB7H=CB5@7<9K=B;;IA7CADF=G=B;D<MHCBIHF=9BHG5B8585DHC;9B=7<9F6G CCGH A9BH5@7@5F=HM5B87CB79BHF5H=CB
#)  .G9C:G<K5;5B8<59LHF57H:CFH<9HF95HA9BHC: αGMBI7@9=BCD5H<=9G αGMBI7@9=BCD5H<=9G=B7@I8=B;)5F?=BGCBG8=G95G9
$+  CGA9H=77CADCG=H=CB:CF=ADFCJ=B;G@99D8=GCF89FCFA5=BH5=B=B;899D
G@99D7CADF=G=B;K=H<5B=5GCAB=:9F5&CFIG5IGHF5@=G5B8DIF9H959LHF57HG
<FCB=7G@99D 8=GCF89FG
)  .G9C:5K=H<5B=59LHF57H:CFH<9HF95HA9BHC:89AM9@=B5H=B;8=G95G9G &I@H=D@9G7@9FCG=G8=G95G9
0(  BH=DGM7<CH=77CADCG=H=CB5B8HF95HA9BHA9H<C8G BH=G7<=NCD<F9B=5CFG7<=NC5T97H=J98=GCF89F
'  0=H<5B=5GCAB=:9F5@57H=897CADCIB8A9H<C8:CF9LHF57H=B;G5A95B8
5DD@=75H=CBC:K=H<5B=5GCAB=:9F5@57H=897CADCIB8
BH==BR5AA5HCFM
.,  '5HIF5@DFC8I7H7CADCG=H=CBG:CFHF95H=B;CFA5B5;=B;GMADHCAGC:588
!5BL=9HM5B889DF9GG=CB
-F95HA9BHC:588=7H=CB!5BL=9HM5B889DF9GG=CB
)  0=H<5BC@=89GIG9:I@:CFH<9HF95HA9BHC:B9IFC89;9B9F5H=J98=G95G9G -F95HA9BHC:B9IFC89;9B9F5H=J98=G95G9G
.,  &I@H=7CADCB9BH:CFAI@5H=CBG -F95HA9BHC:7C;B=H=J9897@=B9@N<9=A9FG8=G95G95B8
CH<9F89A9BH=5G
.,  '=7CH=B9:F99<9F65@7CADCG=H=CB:CFGAC?=B;89588=7H=CB5B8HF95HA9BHC:
G=899T97HG5B8CF5=@A9BHG:FCAGAC?=B;
BH=GAC?=B;
)  .G9C:5K=H<5B=59LHF57H:CFH<9HF95HA9BHC:B9IFCAIG7I@5F8=G95G9G ACHCFB9IFCB8=G95G9G@=?95AMCHFCD<=7@5H9F5@G7@9FCG=G
.,  CADCG=H=CBG5B8A9H<C8G:CFHF95H=B;!"/5GGC7=5H98B9IFC7C;B=H=J9
8=GCF89FG
BH=588=7H=CB
D9FCL=8=G9 5B8 ;@IH5H<=CB9,HF5BG:9F5G9 6M 57H=B; 5G GI6GHF5H9 +5
>5,5B?5F 9H 5@ 56 "H DFCACH9G :CFA5H=CB C: 89B8F=H9G H<FCI;<
 A=A9H=7 9::97H G<K5;5B8<5 5B8 =HG 9LHF57HG =ADFCJ9 9B9F;M @9J
9@G 5B8 A=HC7<CB8F=5@ <95@H< GC =H =G 9::97H=J9 5G 5B 5BL=C@MH=7 ,=B;< 9H
5@ 
CD5A=B9F;=7 57H=J=HM C: 5 8FI; 75B 9B<5B79 A9ACFM 5B8 BIA
69F C: D5D9FG 5F9 DI6@=G<98 G<CK=B; 8CD5A=B9F;=7 57H=J=HM C: G<K5
;5B8<5 FCCH 5F7< )F5?5G< 9H 5@  BIA69F C: in vivo
5B8 7@=B=75@ GHI8=9G <5J9 DFCJ98 H<9 BCCHFCD=7 57H=J=HM C: G<K5;5B8<5
5B8 =HG 9LHF57H <I@9M <9B;5DD5 9H 5@ )=B;5@= 9H
5@  '9IFCDFCH97H=J9 9::97HG C: G<K5;5B8<5 GIDDCFHG =HG 9:Q
757M =B @N9=A9FG D5H=9BHG $I6CM5A5 9H 5@ /9B &IFH<M 9H
5@ 
G<K5;5B8<5 5B8 =HG 9LHF57H <5J9 5BH=GHF9GG 5B8 5BL=C@MH=7 9::97H
5B8 H<9G9 9::97H 5F9 =BJC@J98 =B A9ACFM 9B<5B7=B; 57H=J=HM 5B8 IG98
K<9B BCFA5@ A9BH5@ 57H=J=H=9G C: <IA5B 5F9 5::97H98 MG9B7? 9H
5@  9G=89 H<9 G<K5;5B8<5 FCCH =HG @95: 9LHF57H =B8=75H98
DFC656@9 9::97H CB 5BH=CL=85BH =B8I7H=CB =B H<9 )5F?=BGCBG 8=G95G9
ACIG9 6F5=B +5>5,5B?5F 9H 5@ 56 -<9 8CD5A=B9 D@5MG 5B
=ADCFH5BH 7<5F57H9F =B ACHCF 7CBHFC@ -<9 897F95G9 @9J9@G C: 75H9
7<C@5A=B9G 5B8 CL=85H=J9 GHF9GG 5F9 H<9 =ADCFH5BH F95GCBG C: B9IFC89
;9B9F5H=CB =B )5F?=BGCBG 8=G95G9 5B8 75IG9G @CGG C: ACHCF :IB7H=CB G99B
=B )5F?=BGCBG 8=G95G9 D5H=9BHG &=G<F5 9H 5@ !5@@=K9@@ 
-<9 =B7F95G98 @9J9@G C: 75H97<C@5A=B9 5:H9F G<K5;5B8<5 HF95HA9BH
GI;;9GHG H<5H G<K5;5B8<5 =B8I79G 75H97<C@5A=B9G =B H<9 )5F?=BGCBG
8=G95G9
-<IG 69G=89 5BH=CL=85BH J5F=CIG CH<9F A97<5B=GAG 5F9 7CBG=89F98
HC 69 F9GDCBG=6@9 :CF DFCH97H=J9 9::97H C: G<K5;5B8<5 =B J5F=CIG ',
8=GCF89FG =B7@I8=B; =B<=6=H=CB C: 579HM@ 7<C@=B9GH9F5G9 57H=J=HM =B7F95G9
=B 579HM@7<C@=B9 F979DHCF 9LDF9GG=CB 5BH=@N<9=A9F =B7F95G9 9LDF9G
G=CB C: 579HM@7<C@=B9 F979DHCF C;B=H=J9 =AD5=FA9BH 5B8 8CD5A=B9 F9
79DHCF )5F?=BGCBG 8=G95G9 IFH<9F =H 5@GC 75IG9G =B<=6=H=CB =B ;@I7C
7CFH=7C=8G 5B8 =B7F95G9 =B G9FCHCB=B 7CB79BHF5H=CB GHF9GG 5B8 CH<9F F9
@5H98 8=G95G9 DFCH97H=CB C: A=HC7<CB8F=5 !IBH=B;HCBG 8=G95G9 5B8 =B
7F95G9 =B 7M7@=7 589BCG=B9 ACBCD<CGD<5H9 9F96F5@ =G7<59A=5 IF;
9H 5@  G<K5;5B8<5 =G 7<9A=

UNCORRECTED PROOF
S. Zahiruddin et al. Journal of Ethnopharmacology xxx (xxxx) xxx-xxx
75@@M 9BF=7<98 K=H< BIA9FCIG 57H=J9 7CBGH=HI9BHG A5=B@M GH9FC=85@ 5@?5
@C=8G 5@CB; K=H< @57HCB9G K<=7< 5F9 F9GDCBG=6@9 :CF =HG J5F=CIG B9IFCDFC
H97H=J9 FC@9 =B ', 8=GCF89F
DFCD9F K9@@8C7IA9BH98 D<5FA57C@C;=75@ 57H=J=HM C: H<9 D<MHC
7<9A=75@ 7CADCG=H=CB C: G<K5;5B8<5 =G @57?=B; /5F=CIG =B8=J=8I5@
7CBGH=HI9BHG <5J9 699B =GC@5H98 5B8 7<5F57H9F=G98 :CF H<9=F 6F5=B F9@5H98
8=GCF89FG 6IH GH=@@ B998 HC 8=G7CJ9F 5B8 9LD@CF9 H<9 HF95GIF9 HC =89BH=:M
H<9 7CAD@9H9 6=C57H=J9 7CBGH=HI9BHG =B H<=G D@5BH -<=G KCI@8 79FH5=B@M
<9@D HC DFCACH9 5B 9LH9BG=J9 IG9 C: G<K5;5B8<5 5B8 =HG 9LHF57H 5B8
H<9 89G=;B C: B9K DFC8I7H :CF J5F=CIG 6F5=B 8=GCF89F -<9 56CJ9 QB8=B;G
7@95F@M =B8=75H9 H<5H H<9 IG9 C: G<K5;5B8<5 5B8 =HG 7CBGH=HI9BHG <5G
5 F95GCB56@9 5B8 G7=9BH=Q7 65G=G G<K5;5B8<5 5B8 =HG 9LHF57H G<CK98
7CIBH@9GG DCH9BH=5@ 5G G5:9 5B8 57H=J9 75B8=85H9 =B 6F5=B F9@5H98 8=G
CF89FG &CF9 FC6IGH G7=9BH=Q7 9J=89B79 =B F9@5H=CB HC D<5FA57C@C;=75@
9J5@I5H=CB =B7@I8=B; 8FI; @=?9 DFCD9FH=9G B998G HC 69 D9F:CFA98 =B CF89F
HC DFCACH9 H<9A 5G 5 DCH9BH=5@ 8FI; 75B8=85H9 :CF A5F?9H98 DFC8I7HG
IFH<9F 7@=B=75@ HF=5@G C: 6=C57H=J9 7CADCIB8G 5@CB9 5B8 =B GMB9F;=GH=7
7CA6=B5H=CB 5F9 H<9 A5>CF Q9@8 K<=7< B998G 9LD@CF5H=CB @GC ACF9 F9
G95F7< 5B8 7@=B=75@ =BJ9GH=;5H=CB 5F9 B99898 HC QB8 CIH H<9 57HI5@ A97<
5B=GA 5B8 89H9FA=B9 H<9 CDH=A5@ F5B;9 C: 8CG5;9
Declaration of competing interest
-<9 5IH<CF 897@5F9G BC 7CBR=7H C: =BH9F9GH 5GGC7=5H98 K=H< H<=G DI6@=
75H=CB
Appendix A. Supplementary data
,IDD@9A9BH5FM 85H5 HC H<=G 5FH=7@9 75B 69 :CIB8 CB@=B9 5H <HHDG8C=
CF;>>9D
References
<A98 + $<5B '  05G99A & $<5B 3 #  !C@=GH=7 5DDFC57< =B H<9 A5B5;9A9BH
C: 89DF9GG=CB 5 F9J=9K # "BH9; CAA !95@H<  
?<CCB  )5B89M , -=K5F= , )5B89M +  0=H<5BC@=89 CT9FG B9IFCDFCH97H=CB
5A9@=CF5H9G GHF9GG F9G=GH5B79 5B8 DFC@CB;G H<9 @=:9 9LD97H5B7M C: 59BCF<568=H=G
9@9;5BG LD 9FCBHC@  
BCBMACIG  9BHF5@ CIB7=@ :CF +9G95F7< =B .B5B= &98=7=B9 &=B=GHFM C: !95@H< 5B8
5A=@M 09@:5F9 CJ9FBA9BH C: "B8=5 -<9 .B5B= )<5FA57CDC9=5 C: "B8=5 '9K 9@<=
DD )5FH" /C@IA9"
D<5@9  <<=665  $IA6<5?5FB5 ' + &5H99BI88=B & 5<5H , ! 
,I657IH9 HCL=7=HM GHI8M C: H<9 7CA6=B5H=CB C: ;=BG9B; )5B5L ;=BG9B; 5B8
5G<K5;5B8<5 0=H<5B=5 GCAB=:9F5 =B F5HG 5 G5:9HM 5GG9GGA9BH "B8=5B # )<MG=C@
)<5FA57C@   
FIB57<5@5A /  "B8=;9BCIG ?BCK@98;9 5B8 =BH9@@97HI5@ DFCD9FHM F=;<HG H<9 @5H9BH
@C;=GH=7G 5B8 H<9 CJ9FH 7CB79FBG # "BH9@@97H )FCD +=;<HG  
5=H<5FI " #5=B / 99D , ' ,<FCT , ,5<I # $ '5=? ) $ "@5J5N<5;5B 
0=H<5BC@=89 DF9J9BHG B9IFC89;9B9F5H=CB 6M AC8I@5H=B; <=DDC75AD5@ ;@IH5H<=CB9
6=CGMBH<9G=G 8IF=B; <MDCL=5 )@C, (B9  9
5@?F=G<B5  &=GF5 %  <9AC6CH5B=75@ 5B8 B9IFC@C;=75@ 577CIBHG C: GCA9
5MIFJ98=7 D@5BHG IG9:I@ =B A9BH5@ <95@H< '5H )FC8 #  
5BG5@ ) 5B9F>99 ,  T97H C: K=H<=B=5 GCAB=:9F5 5B8 G<=@5>=H CB 5@7C<C@ 588=7H=CB
=B A=79 )<7C; &5;  ,IDD@ , 
5F7< &  )<5FA57C@C;=75@ A5B=DI@5H=CB C: <IA5B KCF?=B; A9ACFM
)GM7<CD<5FA57C@C;M   
5F?@9M + 8  HH9BH=CB89Q7=H !MD9F57H=J=HM =GCF89F !5B86CC? :CF
=5;BCG=G 5B8 -F95HA9BH :CIFH< 98 -<9 I=@:CF8 )F9GG
5GG5F9C / -5@5B= F5I + )CFFI , +CG5G & $5GHIF9 ,  7EI5G  
"B<=6=H=CB C: ACFD<=B95B8 9H<5BC@A98=5H98 GH=AI@5H=CB C: A9GC@=A6=7 8CD5A=B9
B9IFCBG 6M K=H<5B=5 GCAB=:9F5 FCBH '9IFCG7=  
9@A5?9F + !  =DC@5F 8=GCF89F ' B;@ # &98   
<5HB5;5F & C9@ " +CM - ,<I?@5 ,  $<IF5B5 ,  CAD@9H9 CAD5F=GCB
=GD@5M  9J5@I5H=CB C: 9H<5BC@ 9LHF57HG C: 9BH9@@5 5G=5H=75 5B8 0=H<5B=5
GCAB=:9F5 G<CKG H<5H H<9M 75B BCBGMB9F;=GH=75@@M 5A9@=CF5H9 6=C7<9A=75@ 5B8
69<5J=CIF5@ 85A5;9G =B &)-) =B8I798 )5F?=BGCBG AC89@ C: A=79 )@C, (B9  
9
<5HH57<5FM5 , $ <5HH57<5FM5  ,5=F5A $ <CG5@ ,  BL=C@MH=75BH=89DF9GG5BH
57H=J=HM C: 0=H<5B=5 GCAB=:9F5 ;@M7CK=H<5BC@=89G 5B 9LD9F=A9BH5@ GHI8M
)<MHCA98=7=B9  
=989FA5B #  HH9BH=CB89Q7=H<MD9F57H=J=HM 8=GCF89F 5 G9@97H=J9 CJ9FJ=9K =C@
)GM7<=5HF   
=989FA5B # &=7?  5F5CB9 , / IF657? &  )5HH9FBG C: F9A=GG=CB 5B8
GMADHCA897@=B9 =B 7CB8I7H 8=GCF89F 5 :CIFM95F DFCGD97H=J9 GHI8M C: 5B !
G5AD@9 # A 758 <=@8 8C@9G7 )GM7<=5HFM   
=F@5 ! $9GK5B=  +5= , ' ,=B;< , , 35<F5 0 =@B5G<=B ! ,=B;< , ) 
'9IFCDFCH97H=J9 9T97HG C: 0=H<5B=5 GCAB=:9F5 =B ) =B8I7987C;B=H=J9 8MG:IB7H=CB
5B8 CL=85H=J9 GHF9GG =B A=79 9<5J F5=B IB7H   
CF5< $ ,<5FA5 , ,=@@5 2  ,HFI7HIF5@ 6=C=B:CFA5H=7G65G98 =89BH=Q75H=CB C:
DIH5H=J9 D@5BH 65G98 @958 7CADCIB8G :CF @N<9=A9F =G95G9 -<9F5DM CADIH =C@
<9A  
FCKB + ! @<5@56=   AMCHFCD<=7 @5H9F5@ G7@9FCG=G ' B;@ # &98  

I@@ %  ,IBRCK9F H<9F5DM :CF 7<=@8F9B K=H< GD97=Q7 @95FB=B; 8=S7I@H=9G 8MG@9L=5
5 F5B8CA=G98 7CBHFC@@98 HF=5@ CAD@ -<9F @=B )F57H   
5DIH=  7EI5G  $5GHIF9 , +I=I , 5B89@9HH= , +CAI5@8= )  -<9
GH5B85F8=N98 0=H<5B=5 GCAB=:9F5 IB5@ FCCH 9LHF57H 5@H9FG 65G5@ 5B8
ACFD<=B9=B8I798 CD=C=8 F979DHCF ;9B9 9LDF9GG=CB 7<5B;9G =B B9IFC6@5GHCA5 79@@G
& CAD@ @H9FB5H=J9 &98   
5GH5BCB ' %5GG9@=B # 5DIFCB %  '9IFCDGM7<=5HF=7 7CACF6=8=HM =B C69G=HM FC@9
C: =BR5AA5HCFM DFC79GG9G FCBH B8C7F=BC@  
<9B;5DD5 $ + CK=9 + ,7<@=7<H ) # @99H  F5F # , #=B85@ +  +5B8CA=N98
D@5796C7CBHFC@@98 58>IB7H=J9 GHI8M C: 5B 9LHF57H C: 0=H<5B=5 GCAB=:9F5 :CF 7C;B=H=J9
8MG:IB7H=CB =B 6=DC@5F 8=GCF89F # @=B )GM7<=5HF   
<CI8<5FM & " '5K5N ,  %C8<= &  <5MIF & ' #5@=@ , +=5N ' =@5B= !
 0=H<5BC@=89G 5 B9K 7@5GG C: B5HIF5@ 7<C@=B9GH9F5G9 =B<=6=HCFG K=H< 75@7=IA
5BH5;CB=GH=7 DFCD9FH=9G =C7<9A =CD<MG +9G CAAIB   
5F ' # <5H #  ,5HH= ' $ ,<5FA5 ) + !5A=8  <A58 &  0=H<5BCB9 5B
57H=J9 7CBGH=HI9BH :FCA 0=H<5B=5 GCAB=:9F5 5TCF8G DFCH97H=CB 5;5=BGH '&=B8I798
9L7=HCHCL=7=HM =B B9IFCB@=?9 79@@G &C@ '9IFC6=C@   
5F ' # !5A=8  <A58 &  )<5FA57C@C;=7 CJ9FJ=9K C: K=H<5B=5 GCAB=:9F5 H<9
"B8=5B ;=BG9B; 9@@ &C@ %=:9 ,7=   
<I@9M # '  'CCHFCD=7@=?9 9T97H C: 5G<K5;5B8<5 0=H<5B=5 GCAB=:9F5 % =B A=79
)<MHCH<9F +9G   
=B< ! ,N56C  5A9F  2I 2 05B; ! !I5B; 1   5F8CLC@CB9 A9H<M@
DF9J9BHG :5H 89DCG=H=CB 5B8 =BR5AA5H=CB =B H<9 J=G79F5@ :5H C: A=79 :98 5 <=;<:5H 8=9H
<9A =C@ "BH9F57H  
IACF9 ' .A9?5F & # -5?G5B89 ;@5K9 & & $CH5;5@9 ' +  T97HG C:
K=H<5B=5 GCAB=:9F5 B=7CH=B9 =B8I798 7CB8=H=CB98 D@579 DF9:9F9B79 =B A=79 )<7C; #
  
IF; , <5889 ,  /5B85@ + ,<=J5?IA5F , <5F5B ,  0=H<5B=5 GCAB=:9F5
G<K5;5B8<5 =B B9IFC69<5J=CIF5@ 8=GCF89FG =B8I798 6M 6F5=B CL=85H=J9 GHF9GG =B
FC89BHG 5 GMGH9A5H=7 F9J=9K 5B8 A9H55B5@MG=G # )<5FA )<5FA57C@  

IHH5 $ )5H9@ ) #I@=9B # )  )FCH97H=J9 9T97HG C: 0=H<5B=5 GCAB=:9F5 9LHF57H =B
,(  ACIG9 AC89@ C: 5AMCHFCD<=7 @5H9F5@ G7@9FCG=G LD '9IFC@  
J9F=HH # +C66=BG - 0  FI; 588=7H=CB ID85H=B; 57H=CBG HC <56=HG HC 7CADI@G=CBG
H9B M95FG CB BBI +9J )GM7<C@  
MG9B7? & 0 9F5?G<5B ' ,5BHCG + 5@JC &  BL=9HM 5B8 7C;B=H=J9
D9F:CFA5B79 5HH9BH=CB5@ 7CBHFC@ H<9CFM ACH=CB  
CFA5B & $9FB5 '   &9F;=B; 5MIFJ98=7 5G<K5;5B8<5 K=H< HF58=H=CB5@ <=B9G9
A98=7=B9 )5FH  CIB85H=CB =B 5G<K5;5B8<5 D<MG=C@C;=75@ 9T97HG 7@=B=75@ 9S757M
5B8 DFCD9FH=9G IFF +9G CAD@9A9BH @H9FB &98 +&
<CG5@ , %5@ # ,F=J5GH5J5 + <5HH57<5FM5 , $ .D58<M5M , ' #5=GK5@ $
<5HHCD58<M5M .  "AAIBCAC8I@5HCFM 5B8 ', 9T97HG C: G=HC=B8CG=89G "1
5B8 1 HKC B9K ;@M7CK=H<5BC@=89G :FCA 0=H<5B=5 GCAB=:9F5 )<MHCH<9F +9G 

<CG< - ,I?9 , 2585J  <A98 + 5B9F>99   G<K5;5B8<5 F9J9FG9G H<9
8=9@8F=B=B8I798 7C;B=H=J9 =AD5=FA9BH 6M AC8I@5H=CB C: CL=85H=J9 GHF9GG =B F5H 6F5=B
)<5FA5 +9G   
F5B89 " 9F? & =FA5<9F  /=9H5   =DC@5F 8=GCF89F %5B79H  

FCJ9F  ,<5B8=@M5  ;F5K5@ / =G5F=5 / , ,IB85F   CADIH5H=CB5@
9J=89B79 HC =B<=6=H=CB C: <IA5B 579HM@ 7<C@=B9GH9F5G9 6M K=H<5BC@=89 5 :CF @N<9=A9F
HF95HA9BH # =CAC@ ,HFI7H MB   
IDH5 % +5B5   0=H<5B=5 GCAB=:9F5 5G<K5;5B8<5 5 F9J=9K )<7C; +9J
 
IDH5 & $5IF  0=H<5B=5 GCAB=:9F5 % IB5@ 5A9@=CF5H9G B9IFC89;9B9F5H=CB
5B8 7C;B=H=J9 =AD5=FA9BHG 5GGC7=5H98 K=H< GMGH9A=7 =BR5AA5H=CB & CAD@
@H9FB5H=J9 &98   
IDH5 , $ I5  /C<F5 )  0=H<5B=5 GCAB=:9F5 G<K5;5B8<5 5HH9BI5H9G
5BH=CL=85BH 89:9BG9 =B 5;98 GD=B5@ 7CF8 5B8 =B<=6=HG 7CDD9F =B8I798 @=D=8 D9FCL=85H=CB
5B8 DFCH9=B CL=85H=J9 AC8=Q75H=CBG FI; &9H56C@ FI; "BH9F57H   
!5@@=K9@@   +C@9 C: :F99 F58=75@G =B B9IFC89;9B9F5H=J9 8=G95G9G H<9F5D9IH=7
=AD@=75H=CBG :CF 5BH=CL=85BH HF95HA9BH FI;G ;=B;   
!IH7<=B;G  ,7CHH ! %9K=G IBB=B;<5A   3I@I &98=7=B5@ )@5BHG '5H5@
.B=J9FG=HM )F9GG )=9H9FA5F=HN6IF;
#5M5BH<= & $  BH=89DF9GG5BH 9T97HG C: K=H<5B=5 GCAB=:9F5 :5H 5G<K5;5B8<5
;<FIH<5 9LHF57H =B 9LD9F=A9BH5@ A=79 "BH # )<5FA5 =C ,7=  
#5M5DF5?5G5A  )58A5B56<5B $ '5=F &  0=H<5B5A=89G =B 0=H<5B=5 GCAB=:9F5
:FI=H DFCH97H ) 79@@G :FCA β‐5AM@C=8 F9GDCBG=6@9 :CF @N<9=A9FG 8=G95G9 )<MHCH<9F
+9G   
#5M5DF5?5G5A  ,HF5G6IF;  '5=F &  )CH9BH @=D=8 D9FCL=85H=CB =B<=6=HCFG
:FCA 0=H<5B=5 GCAB=:9F5 :FI=HG -9HF5<98FCB   
#C<B #  -<9F5D9IH=7 DCH9BH=5@ C: 0=H<5B=5 GCAB=:9F5 5 F9DCFH CB
D<MHCD<5FA57C@C;=75@ DFCD9FH=9G "BH # )<5FA5 ,7= +9G  

UNCORRECTED PROOF
S. Zahiruddin et al. Journal of Ethnopharmacology xxx (xxxx) xxx-xxx
$5BM5=M55 & =;5A65F6 , ) FCF55 , $5D=@5 , ,=B;< + +   "B J=JC 9T97H C:
<9F6 0=H<5B=5 GCAB=:9F5 CB =AAIBCAC8I@5HCFM 5B8 5BH=CL=85H=J9 DCH9BH=5@ C: A=@?
=B A=79 CC8 ;F=7 "AAIBC@    
$5IF - $5IF  0=H<5B=5 GCAB=:9F5 5G 5 DCH9BH=5@ 75B8=85H9 HC 5A9@=CF5H9 <=;< :5H
8=9H=B8I798 5BL=9HM 5B8 B9IFC=BR5AA5H=CB # '9IFC=BR5AA5H=CB   
$<5F9 )  "B8=5B &98=7=B5@ )@5BHGB "@@IGHF5H98 =7H=CB5FM GH "B8=5B +9DF=BH
,DF=B;9F "B8=5 )JH %H8 '9K 9@<= "B8=5 D 
$CB5F  ,<5< ' ,=B;< + ,5L9B5 ' $5I@ ,  058<K5 + -<5?IF & $ 
)FCH97H=J9 FC@9 C: G<K5;5B8<5 @95: 9LHF57H 5B8 =HG 7CADCB9BH K=H<5BCB9 CB
G7CDC@5A=B9=B8I798 7<5B;9G =B H<9 6F5=B 5B8 6F5=B89F=J98 79@@G )@C, (B9 
9
$CC6  /C@?CK '   '9IFC6=C@C;M C: 588=7H=CB 5 B9IFC7=F7I=HFM 5B5@MG=G -<9
@5B79H )GM7<=5HFM  
$I6CM5A5 - -C<85  $CA5HGI $  '9IF=H=7 F9;9B9F5H=CB 5B8 GMB5DH=7
F97CBGHFI7H=CB =B8I798 6M K=H<5BC@=89  F # )<5FA57C@   
$I6CM5A5 - -C<85  $CA5HGI $  T97HG C: 5G<K5;5B8<5 FCCHG C: 0=H<5B=5
GCAB=:9F5 CB B9IFC89;9B9F5H=J9 8=G95G9G =C@ )<5FA I@@   
$I@?5FB= , $ <=F   0=H<5B=5 GCAB=:9F5 5B "B8=5B ;=BG9B; )FC;
'9IFC)GM7<CD<5FA57C@ =C@ )GM7<=5HFM   
$IA5F )5@=K5@ ) )5HB5=? ' )5HB5=? +  0=H<5B=5 GCAB=:9F5 D<MHC7<9A=75@G
7CB:9F B9IFCDFCH97H=CB 6M G9@97H=J9 =B<=6=H=CB C: B'CG 5B =B G=@=7C GHI8M HC G95F7<
DCH9BH 5B8 G9@97H=J9 =B<=6=HCFG :CF <IA5B B'(, # -<9CF CADIH <9A  

$IA5F )5HB5=? +  LD@CF=B; B9IFCDFCH97H=J9 DCH9BH=5@ C: 0=H<5B=5 GCAB=:9F5
D<MHC7<9A=75@G 6M =B<=6=H=CB C: @I'7CBH5=B=B; '& F979DHCFG 5B =B G=@=7C
GHI8M &98 !MDCH<9G9G  
$IA5F )5HB5=? +  "B<=6=H=CB C: ;9@5H=B5G9G &&) 5B8 &&) 6M 0=H<5B=5
GCAB=:9F5 D<MHC7<9A=75@G 7CB:9FG B9IFCDFCH97H=CB =B GHFC?9 5B =B ,=@=7C B5@MG=G
"BH9F8=G7=D ,7=   
$IA5F ) $IA5F   T97HG C: FCCH 9LHF57H C: 0=H<5B=5 GCAB=:9F5 =B
'=HFCDFCD=CB=7 57=8=B8I798 7C;B=H=J9 8MG:IB7H=CB 5B8 CL=85H=J9 85A5;9 =B F5HG "BH
# BJ=FCB !95@H< +9G  
$IA5F ) $IA5F   )CGG=6@9 B9IFCDFCH97H=J9 9T97H C: 0=H<5B=5 GCAB=:9F5 FCCH
9LHF57H 5;5=BGH B=HFCDFCD=CB=7 57=8=B8I798 69<5J=CF5@ 6=C7<9A=75@ 5B8
A=HC7<CB8F=5@ 8MG:IB7H=CB =B 5B 5B=A5@ AC89@ C: !IBH=B;HCBG 8=G95G9 # &98 CC8
  
$IA5F , ,95@ # !CK9G & # + $=H9  (?9@@C #  "B J=HFC DFCH97H=J9
9T97HG C: 0=H<5B=5 GCAB=:9F5 % 8IB5@ FCCH 9LHF57H 5;5=BGH <M8FC;9B D9FCL=89 5B8
β‐5AM@C=8  =B8I798 7MHCHCL=7=HM =B 8=T9F9BH=5H98 ) 79@@G )<MHCH<9F +9G 
 
$IA5F ,  +5>5B5B8< & IF5=D5B8=5B   7IH9 5B8 GI657IH9 HCL=7=HM GHI8=9G
C: 5 D5H9BH98 5BH=5BL=9HM DC@M <9F65@ :CFAI@5H=CB -CL=7C@C;M   
$IF5D5H= $ + / H@IF= / , + ,5A=??5BBI - '5=F & ) '  G<K5;5B8<5
K=H<5B=5 GCAB=:9F5 F9J9FG9G β5AM@C=8 =B8I798 HCL=7=HM =B <IA5B B9IFCB5@ 79@@G
=AD@=75H=CBG =B !"/5GGC7=5H98 B9IFC7C;B=H=J9 8=GCF89FG !' )@C, (B9 
9
%5=8@5K &  !CAC9CD5H<=7 FI; )FCJ=B; C: 0=H<5B=5 ,CAB=:9F5 ! C7HCF5@
=GG9FH5H=CB
%MCB + ,<5MK=HN ,  ,<5MK=HN   89QB=H=CB C: 8MG@9L=5 BB MG@9L=5 
 
&5<9F )  -<9 9T97HG C: GHF9GG 5B8 5;=B; CB ;@IH5H<=CB9 A9H56C@=GA ;9=B; +9G
+9J  
&5=HM - 8<=?5F=  <5HH57<5FM5 $ =GK5G , 96B5H< ) $ &5<5F5B5 , 
GHI8M CB 9J5@IH=CB C: 5BH=89DF9GG5BH 9T97H C: "A=DF5A=B9 58>IB7H K=H< GK5;5B8<5
5B8 F5A<= '9D5@ &98 C@@ #   
&5B>IB5H< & # &IF5@=8<5F5  ,H5B85F8=N98 9LHF57H C: 0=H<5B=5 GCAB=:9F5
G<K5;5B8<5 A5F?98@M CTG9HG FCH9BCB9=B8I798 @C7CACHCF 89Q7=HG CL=85H=J9
=AD5=FA9BHG 5B8 B9IFCHCL=7=HM =B FCGCD<=@5 A9@5BC;5GH9F # CC8 ,7= -97<BC@ 
 
&5BC<5F5B , I=@@9A=B # 6=F5A5GIB85F= + , GG5 & & ?65F & ?65F & 
 -<9 FC@9 C: F957H=J9 CLM;9B GD97=9G =B H<9 D5H<C;9B9G=G C: @N<9=A9FG 8=G95G9
)5F?=BGCBG 8=G95G9 5B8 !IBH=B;HCBG 8=G95G9 5 A=B= F9J=9K (L=8 &98 9@@ %CB;9J

&=F>5@=@= & ! 5?<F-565H5659= , & @=N589< ! <5GG9ADCIF  &=FN5>5B=  
9B9H=7 5B8 0=H<5:9F=B 5B5@MG=G C: "F5B=5B B5HIF5@ DCDI@5H=CBG C: 0=H<5B=5
GCAB=:9F5 5B8 0 7C5;I@5BG 6M +) 5B8 !)-% '5H )FC8 CAAIB 

&=G<F5 %  ,=B;<  5;9B5=G ,  ,7=9BH=Q7 65G=G :CF H<9 H<9F5D9IH=7 IG9 C:
0=H<5B=5 GCAB=:9F5 5G<K5;5B8<5 5 F9J=9K @H9FB5H=J9 &98 +9J  
&I?<9F>99 , $IA5F )5HB5=? +  "89BH=Q75H=CB C: DCH9BH=5@ =B<=6=HCFG C: )+)
5 F9;I@5HCF C: 75GD5G9=B89D9B89BH 79@@ 895H< D5H<K5M :FCA 0=H<5B=5 GCAB=:9F5
D<MHC7<9A=75@G :CF 7CA65H=B; B9IFCHCL=7=HM 5 GHFI7HIF965G98 =BG=@=7C GHI8M #
-<9CF CADIH <9A   
'58?5FB= $ &  "B "B8=5B &5H9F=5 &98=75 H<=F8 98 " )CDI@5F )F5?5G<5B %H8
CA65M DD 
'5=8I ) , ,=B;<  $I@?5FB= , $  T97H C: 0=H<5B=5 GCAB=:9F5 FCCH 9LHF57H CB
<5@CD9F=8C@=B8I798 CFC:57=5@ 8MG?=B9G=5 DCGG=6@9 A97<5B=GAG C: 57H=CB # &98 CC8
 
)5B89M  5B= , IHH ) ,5HH= ' $ ,IF= $  *5N= '  &I@H=:IB7H=CB5@
B9IFCDFCH97H=J9 9T97H C: 0=H<5BCB9 5 7CADCIB8 :FCA 0=H<5B=5 GCAB=:9F5 FCCHG =B
5@@9J=5H=B; 7C;B=H=J9 8MG:IB7H=CB MHC?=B9  
)5HK5F8<5B  05FI89  )IG<D5B;585B ) <5HH '  MIFJ985 5B8 HF58=H=CB5@
<=B9G9 A98=7=B9 5 7CAD5F5H=J9 CJ9FJ=9K J=8 5G98 CAD@9A9BH @H9FB &98
 
)=B;5@= . )=@@= + 5H=A5 '  T97H C: GH5B85F8=N98 5EI9CIG 9LHF57H C: 0=H<5B=5
GCAB=:9F5 CB H9GHG C: 7C;B=H=J9 5B8 DGM7<CACHCF D9F:CFA5B79 =B <95@H<M <IA5B
D5FH=7=D5BHG )<5FA57C;B +9G  
)F56I )  )5B7<5D5?9G5B , +5>   7IH9 5B8 GI657IH9 CF5@ HCL=7=HM 5GG9GGA9BH
C: H<9 <M8FC5@7C<C@=7 9LHF57H C: 0=H<5B=5 GCAB=:9F5 FCCHG =B 0=GH5F F5HG )<MHCH<9F
+9G   
)F5?5G< # <CI<5B , 2585J , $ 09GH:5@@ , +5= , ' ,=B;< , )  0=H<5B=5
GCAB=:9F5 5@@9J=5H9G )5F?=BGCB=5B D<9BCHMD9G 6M =B<=6=H=B; 5DCDHCH=7 D5H<K5MG =B
8CD5A=B9F;=7 B9IFCBG '9IFC7<9A +9G   
)F5?5G< # 2585J , $ <CI<5B , ,=B;< , )  '9IFCDFCH97H=J9 FC@9 C: 0=H<5B=5
GCAB=:9F5 FCCH 9LHF57H =B &5B96)5F5EI5H =B8I798 ACIG9 AC89@ C: )5F?=BGCB=GA
'9IFC7<9A +9G   
+56<=  F7=@9 %9 CT 5 CGH5 'C6@9  (I5NN5B= #  '9IFCDFCH97H=J9
9T97H C: + 5 ;@IH5H<=CB9 89F=J5H=J9 C: K=H<5:9F=B  C6H5=B98 H<FCI;< H<9
6=C7CBJ9FG=CB C: K=H<5B=5 GCAB=:9F5 % 8IB5@ 9LHF57H 6M H<9 :IB;IG 695IJ9F=5
65GG=5B5 &C@97I@9G   
+5;<5J5B  ,<5< 3   0=H<5B=5 GCAB=:9F5 5 DF97@=B=75@ GHI8M CB
B9IFCF9;9B9F5H=J9 H<9F5DM :CF GHFC?9 '9IF5@ +9;9B +9G   
+5<A5B - !5G5B & + <CI8<IF= & , $  T97H C: G<K5;5B8<5F=GH5 0=H<5B=5
GCAB=:9F5 CB H<9 ?=8B9M :IB7H=CBG C: A5@9 5B8 :9A5@9 F5HG #5<5B;=FB5;5F .B=J #
=C@ ,7=  
+5>5,5B?5F , &5B=J5G5;5A - ,IF9B8F5B ,  G<K5;5B8<5 @95: 9LHF57H 5 DCH9BH=5@
5;9BH =B HF95H=B; CL=85H=J9 85A5;9 5B8 D<MG=C@C;=75@ 56BCFA5@=H=9G G99B =B 5 ACIG9
AC89@ C: )5F?=BGCBG 8=G95G9 '9IFCG7= %9HH   
+5>5,5B?5F , &5B=J5G5;5A - $F=G<B5AIFH=  +5A5B5H<5B   -<9
B9IFCDFCH97H=J9 9T97H C: K=H<5B=5 GCAB=:9F5 FCCH 9LHF57H =B &)-)=BHCL=75H98 A=79
5B 5B5@MG=G C: 69<5J=CF5@ 5B8 6=C7<9A=75@ J5F=6@9G 9@@ &C@ =C@ %9HH  
+5>5,5B?5F , &5B=J5G5;5A - ,5B?5F / )F5?5G< , &IH<IG5AM + $F=G<B5AIFH=
 ,IF9B8F5B ,  0=H<5B=5 GCAB=:9F5 FCCH 9LHF57H =ADFCJ9G 75H97<C@5A=B9G
5B8 D<MG=C@C;=75@ 56BCFA5@=H=9G G99B =B 5 )5F?=BGCBG 8=G95G9 AC89@ ACIG9 #
H<BCD<5FA57C@   
+5GCC@ & &5@=?  *IF9G<= & , &5B5B  )IG<D5F5> ) ' G=: & ,<9=?< " 
 +979BH ID85H9G =B H<9 HF95HA9BH C: B9IFC89;9B9F5H=J9 8=GCF89FG IG=B; B5HIF5@
7CADCIB8G J=8 5G98 CAD@9A9BH @H9FB &98 
,5A58= $  G<K5;5B8<5 5B7=9BH A98=7=B9 :CF AC89FB H=A9G # B7 =G )F9J
+9A  9
,75FH9NN=B= ) ,D9FCB=   +9J=9K CB GCA9 D@5BHG C: "B8=5B HF58=H=CB5@ A98=7=B9 K=H<
5BH=CL=85BH 57H=J=HM # H<BCD<5FA57C@   
,9<;5@ ' IDH5  /5@@= + $ #CG<= ,  &=@@G # - !5A9@  +5J=B8F5B5H< / 
0=H<5B=5 GCAB=:9F5 F9J9FG9G @N<9=A9FG 8=G95G9 D5H<C@C;M 6M 9B<5B7=B; @CK89BG=HM
@=DCDFCH9=B F979DHCFF9@5H98 DFCH9=B =B @=J9F )FC7 '5H@ 758 ,7= .B=H ,H5H9G A
  
,<5< '   !9F65@ :C@? A98=7=B9G =B BCFH<9FB "B8=5 # H<BCD<5FA57C@ 

,<5F585  ,C@CACB  9J= ) .  -CL=7=HM C: 0=H<5B=5 GCAB=:9F5 FCCH 9LHF57H
=B F5HG 5B8 A=79 "BH # )<5FA57C;B   
,<5FA5  CH<97<5 / $ (><5 ' $  MG@9L=5 5 GC@IH=CB H<FCI;< MIFJ985
9J=89B79G :FCA MIFJ985 :CF H<9 A5B5;9A9BH C: 8MG@9L=5 =B 7<=@8F9B 5 F9J=9K 2.
  
,<5FA5 , $IA5F   "BHFC8I7H=CB HC HF58=H=CB5@ A98=7=B9G C: G9A=5F=8 F9;=CBG "BH
# %=:9 ,7= )<5FA +9G  
,<=885A5@@5MM5 ' +5C + / C885A5B= , ! /9B?5H9G<K5F@I  ;@=ADG9 CB
:CF9GH RCF5 5B8 "B8=5B GMGH9A C: A98=7=B9 D@5BHG C: <=HF58IF;5 8=GHF=7H $5FB5H5?5
"BH # !9F6 &98  
,=B;<  ,5L9B5 $ <5B85B $ IDH5 $ <IH5B= $ $ B5B8 $ $ 
85DHC;9B=7 57H=J=HM C: 5 BCJ9@ K=H<5BC@=89:F99 5EI9CIG :F57H=CB :FCA H<9 FCCHG C:
0=H<5B=5 GCAB=:9F5 IB )<MHCH<9F +9G   
,=B;< ,<5FA5 ) $ I8<9 + ,=B;< ,  =C@C;=75@ 57H=J=H=9G C: 0=H<5B=5
GCAB=:9F5 BB =C@ +9G  
,=B;< + ! '5FG=A<5AIFH<M $ ,=B;<  '9IFCBIHF=9BH =AD57H C: MIFJ98=7
+5G5M5B5 H<9F5DM =B 6F5=B 5;=B; =C;9FCBHC@C;M  
,=B;< ' <5@@5 & #5;9F 89 ) =@75 &  B CJ9FJ=9K CB 5G<K5;5B8<5 5
F5G5M5B5 F9>IJ9B5HCF C: MIFJ985 :F # -F58=H CAD@9A9BH5FM @H9FB &98 ,

-5AC@= , &  ., )5H9BH DD@=75H=CB 'C  D 
-=K5F= , H@IF= / , + 2B85FH F=5G  #5M5BH +  $5IG<=?  9=;9F #  '5=F & '
 0=H<5:9F=B GIDDF9GG9G 9H5 5AM@C=8 =B )) 9LDF9GG=B; 79@@G GHI8=9G :CF -5H
5B8 C75=B9 5GGC7=5H98 B9IFC@C;=75@ 8MG:IB7H=CBG FCBH ;=B; '9IFCG7=  
.88=B * ,5A=I@@5 % ,=B;< / $ #5A=@ , ,  )<MHC7<9A=75@ 5B8 D<5FA57C@C;=75@
DFCQ@9 C: 0=H<5B=5 GCAB=:9F5 IB5@ 5 F9J=9K # DD@ )<5FA579IH ,7= 

/99F9G<  )F5HMIG<5 &5@@=?5 , ,I85FG<=B= $  0=H<5B=5 GCAB=:9F5 5A9@=CF5H9G
GC8=IA J5@DFC5H9 =B8I798 5IGH=GA =B %7 A=79 69<5J=CF5@ 5B8 6=C7<9A=75@
9J=89B79G )<5FA57C@C;=5  
/9B&IFH<M & + +5B>9?5F $ ) +5A5GG5AM  9G<D5B89 &  ,7=9BH=Q7 65G=G :CF
H<9 IG9 C: "B8=5B MIFJ98=7 A98=7=B5@ D@5BHG =B H<9 HF95HA9BH C: B9IFC89;9B9F5H=J9
8=GCF89FG  G<K5;5B8<5 9BH '9FJ ,MGH ;9BHG &98 <9A   
09= 2 2 %=B 0  3<5B; - ! -5B; 2 1 05B; # # 3<CB; &   T97H=J9B9GG C:
HF58=H=CB5@ <=B9G9 A98=7=B95G 5G 5B 58>IB7H H<9F5DM :CF F9:F57HCFM G7<=NCD<F9B=5 5
GMGH9A5H=7 F9J=9K 5B8 A9H55B5@MG=G ,7= +9D  
2585J , $IA5F / ,I?9 , <A98 + , &98=F5HH5 ) $ 5B9F>99  
)FCDCLIF=B8I798 579HM@7<C@=B9 9GH9F5G9 =B<=6=H=CB 5B8 =AD5=FA9BH C: 7C;B=H=J9
:IB7H=CB 5HH9BI5H=CB 6M 0=H<5B=5 GCAB=:9F5 "B8=5B # =C7<9A =CD<MG  


... Medhasagar Rasa®, a proprietary Medhya Rasayana, combines classical herbomineral formulations and herbs to support brain functions and reduce stress. It includes Mahakalyan Vati (Suvarnayukta), Smrutisagar Rasa, Rajata Bhasma (processed silver), and Abhraka Bhasma (processed mica), as well as Medhya Rasayana herbs like Mandookaparni (Centella asiatica), Yashti (Glycyrrhiza glabra), Shankhapushpi (Convolvulus pluricaulis), Guduchi (Tinospora cordifolia), and additional herbs like Ashvagandha (Withania somnifera) and Haridra (Curcuma longa) [11][12][13][14][15][16][17][18]. Suvarna Bhasma (processed gold) in Mahakalyan Vati, enhances cognitive functions and has anxiolytic effects [19]. ...
... Medhya Rasayana herbs are renowned for their memory-enhancing and neuroprotective actions [15][16]. Ashvagandha (Withania somnifera) and Haridra (Curcuma longa) are known to prevent amyloid-β plaque build-up in the brain [17][18]. Medhasagar Rasa therefore shows potential in addressing cognitive decline in MCI through its combination of neuroprotective and memory-enhancing ingredients, offering a promising alternative for improving cognitive function and slowing progression in aging individuals. ...
... Furthermore, the herbs such as Mandookaparni (Centella asiatica), Shankhapushpi (Convolvulus pluricaulis), Yashti (Glycyrrhiza glabra), and Guduchi (Tinospora cordifolia) in Medhasagar Rasa possess memory-enhancing, nootropic, and neuroprotective properties [16,[50][51][52][53][54][55]. Ashvagandha (Withania somnifera) and Haridra (Curcuma longa) are reported to prevent amyloid-β plaque build-up in the brain [17,18]. Ashvagandha (Withania somnifera) has also exhibited a neuroprotective role in neurodegenerative diseases (Alzheimer's, Huntington's, and Parkinson's) by restoring mitochondrial and endothelial functions and mitigating apoptosis, inflammation, and oxidative stress mechanisms [56]. ...
... Ashwagandha (S1) is a supplement that can help reduce stress and insomnia. It is also a rich source of fiber, Fe, and Ca [55]. Bhringraj (S2) is another herbal supplement rich in vitamins E, D, Mg, Fe, and Ca. ...
Article
Full-text available
With the global increase in the use of dietary supplements to provide nutrients in one’s regular diet, these supplements’ potential health risks and benefits have become a topic of significant interest. Interestingly, as dietary supplements, the Food and Drug Administration (FDA) in the United States (USA), Europe, and most countries do not require manufacturers and distributors to obtain approval or provide safety assessments before marketing those products. This research explores for the first time 16 heavy, trace and macro-elemental contents, namely, As, Ni, Cd, Pb, Cu, Co, Mn, Cr, Zn, V, Fe, Al, K, Na, Mg, and Ca, within 24 nutraceutical and herbal supplements marketed in Oman. The research is focusing on ensuring their compositions, concentrations, and freedom of toxic elements. ICP-OES was utilized, preceded by a microwave digestion technique to digest the samples in concentrated HNO3 and HCl (3:1, v/v). The method was validated within linear ranges of 0.03–5.00 ppm and 1.0–200.0 ppm for micro- and macro-elements, respectively, with %recoveries ranging from 90 to 104%. The limits of detection ranged from 0.01 to 0.09 and 0.14 to 0.30 ppm, while the limits of quantification ranged from 0.03 to 0.28 and 0.46 to 0.91 ppm for micro- and macro-elements, respectively. The detected levels were compared to online databases for risk assessment. Although As and Cd were not detected in all samples, Pb was found in nine samples, with some exceeding regulated limits of exposure. About 80% of the samples contained Al, of which two samples were susceptible to serious health risks of exceeding exposure limits in their compiled doses. The locally harvested Omani herbal supplements revealed significant amounts of Zn, Mg, Mn, and Cu. The results highlighted the potential risks associated with both dosage compliance and labeling discrepancies. Graphical Abstract
... The effects of WS root and WS leaf on the nervous system have been investigated in both preclinical and clinical studies. Two recent reviews have comprehensively compiled and analyzed the findings, providing evidence for the effectiveness of WS in treating neurodegenerative diseases such as Alzheimer's, Huntington's, and Parkinson's (17, [39][40][41]. One of the primary reasons for utilizing ashwagandha products is to alleviate stress, which is a common practice in some populations. ...
Article
Full-text available
Ashwagandha or Withania somnifera is an herbal plant belonging to the Solanaceae family. Because of its wide range of phytochemicals, ashwagandha root extract has been used in numerous research studies, either alone or in conjunction with other natural plants, for various biomedical applications, which include its anti-microbial, anti-inflammatory, anti-stress, anti-tumor, cardioprotective, and neuroprotective properties. Additionally, it improves endothelial function, lowers reactive oxygen species, controls apoptosis, and improves mitochondrial function. These properties make it a useful treatment for a variety of conditions, including age-related symptoms, anxiety, neurodegenerative diseases, diabetes, stress, arthritis, fatigue, and cognitive/memory impairment. Despite the numerous benefits of ashwagandha supplementation, there have been just four meta-analyses on the herb’s effectiveness in treating anxiety, neurobehavioral disorders, impotence, and infertility. Moreover, no reviews exist that examine how ashwagandha affects antioxidant response and physical sports performance. Consequently, the goal of this study was to analyze the scientific literature regarding the effects of ashwagandha consumption on antioxidant response and athletic performance.
Article
Full-text available
Aim: This study aimed to find out the impact of the various concentrations of ashwagandha plant on biochemical alterations in diabetic rats.Materials and Methods :Thirty adult male albino mice weighing 150±10g, have been utilized & distributed into 2 main groups. The first group (6rats) has been given a basal diet as control (-), the second main group (24 rats) injected with alloxan to cause diabetes, then distributed into four subgroups. One of them was positive diabetes control. Compared to the various three groups, who consumed a basal diet and administered different levels of ashwagandha plant (2.5%, 5%, 7.5%), for 28 days. When the experiment was complete, after treatment with ashwagandha plant, the mice have been weighed & slaughtered, blood samples have been taken, and the serum was separated to do the required measurements. Each FI, BWG & FER were estimated also blood serum glucose, lipide profile, liver function markers, kidney function levels. Results: exhibited that all groups’ values in (HDL-C) showed statistical differences in relation to control (-). While Group 5 was lower value when compared to control (+). Also (ALP)showed groups 5 exhibited statistical variations than control (+). Groups 2 and 3 demonstrated statistical variations than the others.
Chapter
Since ancient times, traditional medicines have been used for the treatment of varied neurological diseases and symptoms as evidenced in the relics of Indian Ayurvedic medicines and Chinese traditional medicines. Numerous studies have shown the efficacy of various compounds derived from traditionally used medicinal plants in improving the conditions of patients with neurological disorders and in preclinical investigations of neurological disorders. Many medicinal plants and their isolated compounds have demonstrated anti-inflammatory and antioxidant effects in various peripheral nervous systems. Since oxidative stress and inflammation are considered to play a significant role in neurodegeneration and various brain pathogenesis, they provide a certain extent of protection against neurological disorders. Treatment with synthetic drugs is cost-effective; however, clinical trials have failed because of various adverse side effects. Moreover, many drugs available for the treatment of neurodegenerative diseases are for symptomatic treatments rather than for curing the diseases. This highlights the critical need for alternate medicines to treat such diseases. The main objective of this chapter is to provide a detailed comprehensive review of the potential of traditionally used medicines against neurological disorders and to inspire the development of improved, efficient, and innovative therapeutic strategies for the treatment of neurological diseases.
Article
Purpose This review paper delves into the comprehensive understanding of Ashwagandha, spanning its botanic occurrence, conventional applications, extraction techniques and pivotal role in addressing various disorders. Design/methodology/approach Introduction Ashwagandha, also known as Withania somnifera, is a remarkable botanical resource with a rich history of use in traditional medicine. Findings In botany, Withania somnifera thrives in diverse ecosystems, particularly in tropical and subtropical regions. Its extensive distribution across regions, the Canary Islands, South Africa, the Middle East, Sri Lanka, India and China underscores its adaptability and resilience. The traditional uses of Ashwagandha in Ayurvedic and indigenous medicine systems have persisted for over 3,000 years. With over 6,000 plant species utilized historically, India, often regarded as the “botanical garden of the world,” has firmly established Ashwagandha as a cornerstone in traditional healing practices. Originality/value Extraction methods play a pivotal role in harnessing the therapeutic potential of Ashwagandha. Ultrasonic-assisted extraction and high-performance liquid chromatography are among the techniques employed to obtain the key bioactive compounds. Ashwagandha’s significance in modern medicine is underscored by its potential to address a spectrum of health issues. The multifaceted bioactivity of Ashwagandha is attributed to its antioxidant, anti-inflammatory, heart conditions, metabolic disorders, renal ailments, hepatic diseases and adaptogenic properties, making it a subject of increasing interest in contemporary medical research. This review synthesizes the assorted perspectives of Ashwagandha, from its botanical roots and conventional employments to its advanced extraction strategies and its intention to basic well-being challenges, advertising important bits of knowledge for analysts, specialists and healthcare experts alike.
Chapter
Eating disorders are illnesses of the mind and body. Anorexia nervosa, bulimia nervosa, binge eating disorder, etc. are examples of eating disorders that affect people of every ethnic background and age, and pose a serious threat to worldwide public health. Several medicinal plants have demonstrated promising therapeutic properties for addressing various aspects of eating disorders. For example, Nigella sativa exhibits anxiolytic and appetite-regulating effects, suggesting its potential utility in treating anorexia nervosa. Additionally, the appetite-suppressing qualities of herbal therapies like Centella asiatica have been studied, making them viable supplementary therapy for people who struggle with excessive consumption of food. Overall, integrating medicinal plants into comprehensive treatment approaches for eating disorders holds promise for improving clinical outcomes and enhancing the holistic well-being of affected individuals.
Article
Full-text available
Ayurveda is a Sanskrit word, which means "the scripture for longevity". It represents an ancient system of traditional medicine prevalent in India and in several other south Asian countries. It is based on a holistic view of treatment which is believed to cure human diseases through establishment of equilibrium in the different elements of human life, the body, the mind, the intellect and the soul [1].
Article
Full-text available
The bioconversion of Withania somnifera extract by the fungus Beauveria bassiana leads to cysteine and glutathione derivatives of withaferin A at the C-6 position. The compounds were purified and fully characterized by 1D-NMR, 2D-NMR, and HRMS analysis. The glutathione derivative CR-777 was evaluated as a neuroprotective agent from damage caused by different neurotoxins mimicking molecular symptoms in Parkinson´s disease (PD), including 1-methyl-4-phenylpyridinium (MPP+), 6-hydroxydopamine (6-OHDA), and α-synuclein (α-Syn). CR-777, at nanomolar concentrations, protected dopaminergic and cortical neurons. In 6-OHDA-treated neurons, CR-777 increased cell survival and neurite network and decreased the expression of α-Syn. Using specific inhibitors of cell toxicity signaling pathways and specific staining experiments, the observed role of CR-777 seemed to involve the PI3K/mTOR pathway. CR-777 could be considered as a protective agent against a large panel of neuronal stressors and was engaged in further therapeutic development steps.
Article
Full-text available
Background: Systemic inflammation driven neuroinflammation is an event which correlates with pathogenesis of several neurodegenerative diseases. Therefore, targeting peripheral and central inflammation simultaneously could be a promising approach for the management of these diseases. Nowadays, herbal medicines are emerging as potent therapeutics against various brain pathologies. Therefore, in this contemporary study, the neuroprotective activity of Ashwagandha (Withania somnifera) was elucidated against the inflammation associated neurodegeneration and cognitive impairments induced by systemic LPS administration using in vivo rat model system. Methods: To achieve this aim, young adult wistar strain male albino rats were randomized into four groups: (i) Control, (ii) LPS alone, (iii) LPS + ASH-WEX, (iv) ASH-WEX alone. Post regimen, the animals were subjected to Rotarod, Narrow Beam Walking and Novel Object Recognition test to analyze their neuromuscular coordination, working memory and learning functions. The rats were then sacrificed to isolate the brain regions and expression of proteins associated with synaptic plasticity and cell survival was studied using Western blotting and Quantitative real time PCR. Further, neuroprotective potential of ASH-WEX and its active fraction (FIV) against inflammatory neurodegeneration was studied and validated using in vitro model system of microglial conditioned medium-treated neuronal cultures and microglial-neuronal co-cultures. Results: Orally administered ASH-WEX significantly suppressed the cognitive and motor-coordination impairments in rats. On the molecular basis, ASH-WEX supplementation also regulated the expression of various proteins involved in synaptic plasticity and neuronal cell survival. Since microglial-neuronal crosstalk is crucial for maintaining CNS homeostasis, the current study was further extended to ascertain whether LPS-mediated microglial activation caused damage to neurons via direct cell to cell contact or through secretion of inflammatory mediators. ASH-WEX and FIV pretreatment was found to restore neurite outgrowth and protect neurons from apoptotic cell death caused by LPS-induced neuroinflammation in both activated microglial conditioned medium-treated neuronal cultures as well as microglial-neuronal co-cultures. Conclusion: This extensive study using in vivo and in vitro model systems provides first ever pre-clinical evidence that ASH-WEX can be used as a promising natural therapeutic remedial for the prevention of neurodegeneration and cognitive impairments associated with peripheral inflammation and neuroinflammation.
Article
Full-text available
The key objective of this present study was to analyze the effect(s) of Ashwagandharishta on the kidney functions of both male and female Albino rats. Chronic toxicity tests were also done. Following treatments the rats were observed for 51 days to know the effects of Ashwagandharishta on kidney functions considering 3 parameters such as serum urea, creatinine and uric acid. Our results failed to exhibit a significant increase in serum urea level at low dose (P<0.01), medium dose (P<0.05) and at high dose (P<0.001) in male rat groups; but with female rat groups our results showed significant increase in serum urea level at three dose levels. Regarding serum creatinine level male rats and female rats showed a trend of increase in level at different dose but effects were insignificant except medium dose in male rats (P<0.05). Regarding serum uric acid level our results failed to show a significant increase irrespective of dose. Jahangirnagar University J. Biol. Sci. 8(1): 1-7, 2019 (June)
Article
Full-text available
Morphine- and ethanol-induced stimulation of neuronal firing of ventral tegmental area (VTA) dopaminergic neurons and of dopamine (DA) transmission in the shell of the nucleus accumbens (AcbSh) represents a crucial electrophysiological and neurochemical response underlying the ability of these compounds to elicit motivated behaviors and trigger a cascade of plasticity-related biochemical events. Previous studies indicate that the standardized methanolic extract of Withania somnifera roots (WSE) prevents morphine- and ethanol-elicited conditioned place preference and oral ethanol self-administration. Aim of the present research was to investigate whether WSE may also interfere with the ability of morphine and ethanol to stimulate VTA dopaminergic neurons and thus AcbSh DA transmission as assessed in male Sprague-Dawley rats by means of patch-clamp recordings in mesencephalic slices and in vivo brain microdialysis, respectively. Morphine and ethanol significantly stimulated spontaneous firing rate of VTA neurons and DA transmission in the AcbSh. WSE, at concentrations (200–400 μg/ml) that significantly reduce spontaneous neuronal firing of VTA DA neurons via a GABAA- but not GABAB-mediated mechanism, suppressed the stimulatory actions of both morphine and ethanol. Moreover, in vivo administration of WSE at a dose (75 mg/kg) that fails to affect basal DA transmission, significantly prevented both morphine- and ethanol-elicited increases of DA in the AcbSh. Overall, these results highlight the ability of WSE to interfere with morphine- and ethanol-mediated central effects and suggest a mechanistic interpretation of the efficacy of this extract to prevent the motivational properties of these compounds.
Article
Background Bisphenol A (BPA), a major endocrine disruptor and a xenobiotic compound is used abundantly in the production of polycarbonate plastics and epoxy resins. Human exposure to this compound is primarily via its leaching from the protective internal epoxy resin coatings of containers into the food and beverages. In addition, the plastics used in dental prostheses and sealants also contain considerable amount of BPA and have a high risk of human exposure. Since it is a well-known endocrine disruptor and closely mimics the molecular structure of human estrogen thereby impairing learning and memory. Withania somnifera (Ws), commonly known as Ashwagandha is known for its varied therapeutic uses in Ayurvedic system of medicine. The present study was undertaken to demonstrate the impairment induced by BPA on the spatial learning, working memory and its alleviation by Ws in Swiss albino mice. The study was conducted on thirty Swiss albino mice, randomly distributed among three groups: control, BPA and BPA + Ws. The behavioral recovery after treatment with Ws was investigated using the Y-maize and Morris water maize test. Whereas, for the estimation of recovery of NMDA receptor which is related to learning and memory in hippocampus region by western blot and immunohistochemistry. Furthermore, the oxidative stress and antioxidant level was assessed by biochemical tests like MDA, SOD and catalase. Results The study revealed that administration of Ws alleviated the behavioral deficits induced by BPA. Alongside, Ws treatment reinstated the number of NMDA receptors in hippocampus region and showed anti-oxidative property while ameliorating the endogenous anti-oxidant level in the brain. Conclusion These findings suggest that Ws significantly ameliorates the level of BPA intoxicated oxidative stress thereby potentially treating cognitive dysfunction which acts as the primary symptom in a number of neurodegenerative diseases.
Research
Emotions are the basic feelings of human beings. All of us have felt unhappy, "down," or discouraged at times in our lives. But when somebody feels anxious, hopeless, helpless, worthless, guilty, hurt, restless or irritable, it comes under the categorization of depression. Depression is a disorder of mood that produces sad feelings, negative thoughts, disruptions of sleep, appetite, thinking, and energy level. Globally, more than 300 million people of all ages suffer from depression. The burden of depression is 50% higher for females than males. USM enlists whole Usool-e-ilaj of depression under the heading of ilaj bil ghiza, ilaj bil dawa and ilaj bil tadbeer. In ilaj bil dawa many drugs have been used for the treatment of depression but herbal medications in psychiatry are under research while more than 20 herbal remedies have been identified that may potentially be applied in medicine as anti-depressive, anxiety-relieving or sleep-inducing agents.
Article
Plant based lead compounds have been historically incredible as a source of therapeutic agents for various complex disorders including Alzheimer's disease (AD). AD is one of the leading neurodegenerative disorder in which the underlying risk factors remain largely unclear and presently, there is no disease modifying treatment available. Despite its potential, to date only few compounds have entered for clinical trials. Herein, we described the identification of plant based lead compounds for treatment of AD through an integrative approach of pharmacokinetics and structure bioinformatics approach. In particular we performed screening of lead compounds from 3 traditional medicinal plants namely Withania somnifera, Bacopa monnieri and Morus alba, which are known to have potential for treatment of neurodegenerative disease. We retrieved a total of 210 plant based compounds of which 21 compounds were screened based on their pharmacokinetic properties. Further, Docking study against 7 known AD associated targets were carried out to identify the binding sites and direct interacting residues. In addition we investigate the stable and reliable binding mechanism of top such plant compounds against 3 targets through molecular docking followed by Molecular Dynamic(MD) simulation. The results obtained in the study revealed that 3 drug compounds namely Morusin (MRSN), Withanone (WTHN) and 27-Hydroxywithanolide B (HWTHN) were identified as putative lead compounds against mono amine oxidase (MAOB), Beta-secretase 1(BACE1) and phosphodiesterase 4D.